寇俊萍中国药科大学教授医药科学创新人物科技创新网

寇俊萍，女，汉族，1972年12月，博士，中西医结合基础（药学），教授，博士生导师。中国药科大学中药学院副院长，中药复方研究室主任。国家自然科学基金中医中药学科同行评议专家，科技部国际科技合作计划评价专家，教育部科技成果与奖励评审专家，南京市科技评审专家，中国实验方剂学杂志副主任编委。

教育及工作经历：

2020.9- 至今，中国药科大学，教务处副处长

2015.09- 2020.07，中国药科大学，中药学院副院长

2014.06-2014.07，美国耶鲁大学，访问学者

2009.06-至今，中国药科大学，教授(破格晋升)

2007.10-2008.10，日本岐阜药科大学，访问学者

2005.06-2009.05，中国药科大学，副研究员(破格晋升)

2001.09-2005.06，南京大学，生理学专业在职博士, 导师徐强教授

2000.06-2005.06，中国药科大学，助理研究员

1996.09-2000.06，中国药科大学，中药学专业在职硕士，导师严永清教授

1994.08-2000.06，中国药科大学，见习研究员

1989.09-1994.06，中国药科大学，中药药理学士

学术兼职：

1、国家自然科学基金医学部中医中药学科同行评议专家。

2、教育部科技成果与奖励评审专家。

3、世界中医药联合会中医药免疫/网络药理学专业委员会常务理事。

4、中华中医药学会中药实验药理分会常务委员。

5、中国药理学会网络药理专业委员会委员。

6、江苏省药理学会理事/抗炎免疫药理专委会副主任委员。

7、中国实验方剂学杂志/中国药科大学学报编委。

研究领域：

中药有效成分的作用靶点发现和相关信号通路研究；中药复方作用机理研究；心脑血管疾病的炎性机制。

承担科研项目情况：

先后主持国家自然科学基金青年基金（麦冬皂苷防治静脉血栓的抗粘附机制研究）、面上项目（从1型组胺受体途径探索当归芍药散异病同治原理研究、基于NMMHCⅡA-TF信号通路探讨麦冬皂苷防治血栓性疾病的新机制、生脉散有效成分群调控AMPK/NMMHCIIA/14-3-3 防治心肌缺血再灌注损伤多靶点整合机制研究），国家十一五科技支撑计划（以定向吸附技术为先导探索中药有效成分作用靶点的方法），新世纪优秀人才支持计划（鲁斯可皂苷元的功能靶标发现和相关信号转导通路研究）等10余项国家省部级课题；主持完成企业委托课题十余项（在注射用益气复脉（冻干）发挥疗效中的效应物质及其作用特点研究、丹参口服液的药效毒理等）；作为项目副组长承担2项国家科技部重大新药创制科技专项，主要参与完成“863”项目、国家自然科学科学基金重大研究计划、教育部重点课题、江苏省自然科学基金、企业委托课题等研究项目20余项。

1、麦冬皂苷防治静脉血栓的抗粘附机制研究(国家自然科学基金青年基金，30300451, 19万)。

2、以定向吸附技术为先导探索中药有效成分作用靶点的方法（“十一五”国家科技支撑计划，2006BAI08B05-08，30万）。

3、鲁斯可皂苷元的功能靶标发现和相关信号转导通路研究(教育部新世纪优秀人才支持计划, NCET-07-0849, 25万)。

4、从1型组胺受体途径探索当归芍药散异病同治原理研究(国家自然科学基金30873322, 31万)。

5、基于组织因子及其信号转导途径的异喹啉生物碱类成分的构效关系与作用机理研究(教育部中央高校基本科研业务费专项资金项目,JKZ2009010, 15万)。

6、新型天然抗过敏化合物THBP的作用机制研究（南京市留学回国人员科技活动择优资助项目，3万）。

科研成果：

近年来重点围绕血管功能紊乱相关疾病,开展中药有效靶点发现和中药及复方作用机理研究, 已识别中药麦冬有效成分的特异性结合蛋白NMMHC IIA为调节内皮细胞组织因子表达与静脉血栓形成的关键功能蛋白，为丰富静脉血栓形成的病理机制奠定坚实基础；优化生脉制剂抗心肌缺血缺氧的有效成分群配伍比例，阐明其调控各自关键功能蛋白及相关信号转导通路等多途径发挥心肌保护效应的作用机制；为中药复方有效成分群组方设计及中成药的二次开发，提供新的研究实例和技术方法参考；诠释生脉制剂及其有效成分防治心脑血管疾病的多途径作用特点，为中成药的评价和临床合理应用提供参考依据。已发表学术论文140余篇，获专利证书17项，指导及协助指导57名研究生毕业。近5年以通讯/共同通讯作者发表SCI论文28篇，单篇最高影响因子5.255，单篇他引次数最高65次，以第1发明人获专利证书6项。

1 脑缺血后炎症反应诱导血管损伤的分子机制、靶标发掘和中药干预吕燕妮;寇俊萍;余伯阳;钱贻崧;付龙生南昌大学第一附属医院 2019

2 麦冬的系统研究余伯阳;寇俊萍;程志红;徐强;吴弢;唐晓清;徐珞珊;徐国钧中国药科大学 2006

发明公开：

[1]李剑, 张蕙, 张媛媛, 夏云, 寇俊萍, 倪洁, 岳孟, 徐向阳, 张庆晓, 邹欣怡, 张娇娇. 一种肺气虚痰热证动物模型构建方法[P]. 江苏省: CN120982468A, 2025-11-21.

[2]寇俊萍, 宫帅帅, 包亮英, 李芳, 张媛媛. PEAK1作为脑缺血再灌注损伤诊断和治疗靶点的应用[P]. 江苏省: CN120310893A, 2025-07-15.

[3]寇俊萍, 唐嘉辉, 张媛媛, 宫帅帅, 李芳. 泛素特异性蛋白酶28抑制剂在制备脓毒症防治药物中的应用[P]. 江苏省: CN120168442A, 2025-06-20.

[4]寇俊萍, 刘元恺, 唐嘉辉, 张媛媛, 李芳, 宫帅帅. 一种酯类化合物在制备抗血栓药物中的应用[P]. 江苏省: CN120131656A, 2025-06-13.

[5]寇俊萍, 唐嘉辉, 张媛媛, 宫帅帅, 李芳. 一种酯类化合物在制备脓毒症防治药物中的应用[P]. 江苏省: CN120131657A, 2025-06-13.

[6]寇俊萍, 宫帅帅, 余俊河, 李芳, 张媛媛. 西曲瑞克的应用[P]. 江苏省: CN117771344A, 2024-03-29.

[7]李芳, 寇俊萍, 林萍萍. 氨基酰化酶1作为靶点在制备或筛选预防或治疗心肌肥大药物中的应用[P]. 江苏省: CN117568460A, 2024-02-20.

[8]寇俊萍, 刘金成, 赵庆飞, 李芳, 张媛媛, 宫帅帅. 一种酯类化合物的应用[P]. 江苏省: CN117159549A, 2023-12-05.

[9]尹琪, 杨雅茹, 朱紫含, 曹雯悦, 梅轩毓, 孔诗怡, 古丽米热·艾尼瓦尔, 刘金玲, 胡洛嘉, 倪陈崟, 童浩仁, 冯欣, 寇俊萍. 一种治疗炎症性痤疮的中药提取物组合物[P]. 江苏省: CN117159660A, 2023-12-05.

[10]寇俊萍, 张媛媛, 李月. β-1,4-半乳糖基转移酶1及其抑制剂在制备治疗急慢性肝病药物中的应用[P]. 江苏省: CN116794308A, 2023-09-22.

[11]寇俊萍, 宫帅帅, 代玉洁. 比卡鲁胺在制备防治脑血管疾病药物中的应用[P]. 江苏省: CN116763771A, 2023-09-19.

[12]寇俊萍, 张媛媛, 李月. 左甲状腺素钠在制备预防或治疗肝损伤药物中的应用[P]. 江苏省: CN116440111A, 2023-07-18.

[13]寇俊萍, 杨雅茹, 杨秉叶. 一种治疗痤疮的组合物及其制备方法[P]. 江苏省: CN115444912A, 2022-12-09.

[14]张媛媛, 潘子倩, 寇俊萍, 张力元, 阎琨. 一种用于改善细颗粒物诱导肺损伤的中药组方[P]. 江苏省: CN115227772A, 2022-10-25.

[15]寇俊萍, 马慧芬, 李芳, 宫帅帅, 张媛媛, 余伯阳. N-乙酰葡萄糖胺作为标志物在制备诊断缺血性脑中风试剂中的应用[P]. 江苏省: CN113462744A, 2021-10-01.

[16]寇俊萍, 张媛媛, 潘雪薇, 宫帅帅, 余伯阳. 鲁斯可皂苷元在制备脑出血防治药物中的应用[P]. 江苏省: CN112843070A, 2021-05-28.

[17]寇俊萍, 张媛媛, 王慧敏, 许梦晨, 李旺. 预防和治疗痛风的中药组合物及其制备方法与应用[P]. 江苏省: CN112353909A, 2021-02-12.

[18]余伯阳, 李芳, 赖琼, 寇俊萍, 张鹿. 5-oxo-ETE及其氧桥二十烷类受体在急性心肌梗塞中的应用[P]. 江苏省: CN111650380A, 2020-09-11.

[19]李芳, 余伯阳, 赖琼, 寇俊萍, 袁光英. 支链氨基转移酶1和/或支链氨基转移酶2的应用[P]. 江苏省: CN111562373A, 2020-08-21.

[20]寇俊萍, 张媛媛, 潘雪薇, 余伯阳, 王美娟. 注射用益气复脉(冻干)的医药用途[P]. 江苏省: CN110974904A, 2020-04-10.

[21]寇俊萍, 张媛媛, 刘元恺, 余伯阳, 徐晗. 注射用益气复脉(冻干)或鲁斯可皂苷元预防药物性器官出血的用途[P]. 江苏省: CN110882258A, 2020-03-17.

[22]余伯阳, 李永伟, 戚进, 寇俊萍, 周水平, 李瑞明, 罗学军, 王瑞静. 一种新的短葶山麦冬鲁斯可甾体皂苷类化合物及其制备方法和应用[P]. 天津: CN107383154A, 2017-11-24.

[23]余伯阳, 李永伟, 戚进, 寇俊萍, 周水平, 李瑞明, 何毅, 钱长敏. 一种短葶山麦冬甾体皂苷化合物及其制备方法和应用[P]. 天津: CN107383155A, 2017-11-24.

[24]林森森, 杨梅, 李航, 袁胜涛, 孙立, 高颖生, 李瑶, 寇俊萍. 一类新型1－氨基－2－羟基－3－四氢咔唑－丙烷类化合物及其抗肿瘤用途[P]. 江苏: CN107266353A, 2017-10-20.

[25]余伯阳, 寇俊萍, 吴炎. 鲁斯可皂苷元异构体在制备药物中的应用[P]. 江苏: CN107158007A, 2017-09-15.

[26]余伯阳, 赵亚铮, 张媛媛, 寇俊萍, 戚进, 吴炎. 麦冬皂苷元用于制备组织因子介导疾病的药物的应用[P]. 江苏: CN106727613A, 2017-05-31.

[27]余伯阳, 施国庆, 张剑, 寇俊萍, 谢鑫. 一种抗疲劳的组合物[P]. 云南: CN104397709A, 2015-03-11.

[28]余伯阳, 施国庆, 张剑, 寇俊萍, 谢鑫. 一种改善疲劳状况的组合物[P]. 云南: CN104397710A, 2015-03-11.

[29]寇俊萍, 余伯阳, 褚纯, 柴程芝, 庄先飞. 一种防治急慢性心血管疾病的中药组合物[P]. 江苏: CN103961361A, 2014-08-06.

[30]余伯阳, 李永伟, 戚进, 张媛媛, 寇俊萍, 黄桢. 短亭山麦冬偏诺型甾体皂苷类新化合物分离鉴定及用途[P]. 江苏: CN103755774A, 2014-04-30.

[31]寇俊萍, 余伯阳, 鹿思思, 吕燕妮, 刘倩. 2-O-α-L-鼠李糖-4,6,4′-三羟基二苯甲酮作为热休克蛋白90抑制剂的医药用途[P]. 江苏: CN102961391A, 2013-03-13.

[32]寇俊萍, 戚进, 李赛谋, 余伯阳. 一种抗过敏天然产物THBP的制备方法[P]. 江苏: CN102659864A, 2012-09-12.

[33]寇俊萍, 朱丹妮, 徐娅妮, 曹旦华. 1,2,3,4,6-O-五没食子酰葡萄糖及其组合物在制备镇痛药物中的医药用途[P]. 江苏: CN102657666A, 2012-09-12.

[34]寇俊萍, 葛海霞, 庄先飞, 俞晨洁, 樊梦霖, 俞苏岚, 张明. 4-羟基查尔酮防治急性肺损伤、脓毒血症及炎症的医药用途[P]. 江苏: CN102657636A, 2012-09-12.

[35]寇俊萍, 张冠军, 余伯阳. 一种肌球蛋白ATP酶活性微量测定方法及其应用[P]. 江苏: CN102288601A, 2011-12-21.

[36]戚进, 宋晓晨, 余伯阳, 朱丹妮, 寇俊萍. 哈巴俄苷类成分的医药用途[P]. 江苏: CN102247394A, 2011-11-23.

[37]余伯阳, 马璇, 戚进, 寇俊萍, 马家骅, 索志荣, 杨兴旺, 杨占国. 一种柴胡皂苷的提取纯化方法[P]. 四川: CN102166235A, 2011-08-31.

[38]寇俊萍, 余伯阳, 戚进, 稻垣直树, 朱丹妮. 2-Ο-α-L-鼠李糖-4,6,4′-三羟基二苯甲酮的医药用途[P]. 江苏: CN101816668A, 2010-09-01.

[39]寇俊萍, 余伯阳, 戚进, 稻垣直树, 朱丹妮. 2-O-α-L-鼠李糖-4,6,4′-三羟基二苯甲酮的医药用途[P]. 江苏: CN101439040, 2009-05-27.

[40]柴程芝, 余伯阳, 朱丹妮, 寇俊萍. 一种治疗痛经的中药组合物及其制备方法[P]. 江苏: CN101406531, 2009-04-15.

[41]余伯阳, 蒋文雯, 寇俊萍, 张剑, 卢灯翠. 异喹啉生物碱类作为组织因子抑制剂的医药用途[P]. 江苏: CN101327214, 2008-12-24.

[42]寇俊萍, 余伯阳. 麦冬皂苷D作为组织因子途径抑制剂的医药用途[P]. 江苏: CN101327221, 2008-12-24.

[43]余伯阳, 蒋文雯, 寇俊萍. 组织因子途径抑制剂的微孔板筛选方法及其应用[P]. 江苏: CN101201314, 2008-06-18.

[44]余伯阳, 寇俊萍, 张建宏, 朱丹妮, 戚进, 严永清. 一种治疗心脑血管疾病的中药有效成分组合物及其用途[P]. 江苏: CN101129395, 2008-02-27.

[45]余伯阳, 李仲树, 寇俊萍, 周丽娟. 防治心脑血管疾病的中药组合物[P]. 福建: CN101129469, 2008-02-27.

[46]余伯阳, 寇俊萍, 黄娅琳, 蒋文雯, 刘吉华. 一种防治炎症相关心脑血管疾病的药物靶标及其抑制剂[P]. 江苏: CN101125146, 2008-02-20.

[47]余伯阳, 刘吉华, 奚涛, 蔡金龙, 周祥, 寇俊萍. 一种具有降脂减肥作用的功能食品[P]. 江苏: CN101095520, 2008-01-02.

[48]余伯阳, 刘吉华, 蔡金龙, 周祥, 寇俊萍. 一种具有抗氧化衰老作用的功能食品[P]. 江苏: CN101095521, 2008-01-02.

[49]寇俊萍, 张建宏, 朱丹妮, 戚进, 余伯阳, 严永清. 一种防治心脑血管疾病的中药有效部位组合物及制备方法[P]. 江苏: CN101028437, 2007-09-05.

[50]余伯阳, 寇俊萍, 周敏华, 朱丹妮, 袁胜涛. 一种沉香叶提取物及其医药和保健用途[P]. 江苏: CN101011499, 2007-08-08.

[51]余伯阳, 马宏跃, 寇俊萍, 严永清. 一种抗炎的中药组合物及其制备方法和用途[P]. 江苏: CN1947729, 2007-04-18.

[52]严永清, 朱丹妮, 林志宏, 寇俊萍, 余伯阳. 一种保健食品及其制备方法[P]. 江苏: CN1943419, 2007-04-11.

[53]寇俊萍, 田友清, 李林洲, 余伯阳, 朱丹妮, 严永清. 鲁斯可皂苷元及其皂苷在制备防治血栓疾病药物中的应用[P]. 江苏: CN1596900, 2005-03-23.

[54]余伯阳, 张伟, 刘吉华, 严永清, 寇俊萍. 低毒高纯度雄黄的制备方法[P]. 江苏: CN1557334, 2004-12-29.

[55]朱丹妮, 王秋娟, 高山林, 寇俊萍, 徐宏江. 黄花倒水莲总皂苷及其药物组合物与制备方法[P]. 江苏: CN1431221, 2003-07-23.

[56]朱丹妮, 寇俊萍, 马仁强, 严永清. 中药黄花倒水莲在制药中的应用[P]. 江苏: CN1382476, 2002-12-04.

[57]严永清, 朱丹妮, 林志宏, 余伯阳, 寇俊萍. 一种防治老年痴呆的中药组合物[P]. 江苏: CN1370592, 2002-09-25.

发明授权：

[1]寇俊萍, 张媛媛, 李月. 左甲状腺素钠在制备预防或治疗肝损伤药物中的应用[P]. 江苏省: CN116440111B, 2025-11-14.

[2]寇俊萍, 宫帅帅, 代玉洁. 比卡鲁胺在制备防治脑血管疾病药物中的应用[P]. 江苏省: CN116763771B, 2025-06-03.

[3]寇俊萍, 刘金成, 赵庆飞, 李芳, 张媛媛, 宫帅帅. 一种酯类化合物的应用[P]. 江苏省: CN117159549B, 2025-02-14.

[4]张媛媛, 潘子倩, 寇俊萍, 张力元, 阎琨. 一种用于改善细颗粒物诱导肺损伤的中药组方[P]. 江苏省: CN115227772B, 2023-07-11.

[5]寇俊萍, 马慧芬, 李芳, 宫帅帅, 张媛媛, 余伯阳. N-乙酰葡萄糖胺作为标志物在制备诊断缺血性脑中风试剂中的应用[P]. 江苏省: CN113462744B, 2023-06-23.

[6]李芳, 余伯阳, 赖琼, 寇俊萍, 袁光英. 支链氨基转移酶1和/或支链氨基转移酶2的应用[P]. 江苏省: CN111562373B, 2022-05-10.

[7]张媛媛, 寇俊萍, 汪雨薇, 余伯阳, 范瑞平. 鲁斯可皂苷元防治PM-(2.5)导致的机体器官损伤的医药用途[P]. 江苏省: CN110934878B, 2022-03-01.

[8]余伯阳, 李永伟, 戚进, 张媛媛, 寇俊萍, 黄桢. 短葶山麦冬偏诺型甾体皂苷类化合物的分离鉴定及用途[P]. 江苏省: CN103755774B, 2016-11-09.

[9]寇俊萍, 戚进, 李赛谋, 余伯阳. 一种抗过敏天然产物THBP的制备方法[P]. 江苏省: CN102659864B, 2014-09-03.

[10]寇俊萍, 朱丹妮, 徐娅妮, 曹旦华. 1,2,3,4,6-O-五没食子酰葡萄糖及其组合物在制备镇痛药物中的医药用途[P]. 江苏省: CN102657666B, 2013-06-12.

[11]寇俊萍, 张冠军, 余伯阳. 一种肌球蛋白ATP酶活性微量测定方法及其应用[P]. 江苏省: CN102288601B, 2012-12-12.

[12]戚进, 宋晓晨, 余伯阳, 朱丹妮, 寇俊萍. 哈巴俄苷类成分的医药用途[P]. 江苏省: CN102247394B, 2012-09-05.

[13]余伯阳, 马璇, 戚进, 寇俊萍, 马家骅, 索志荣, 杨兴旺, 杨占国. 一种柴胡皂苷的提取纯化方法[P]. 四川省: CN102166235B, 2012-07-25.

[14]余伯阳, 寇俊萍, 周敏华, 朱丹妮, 袁胜涛. 一种沉香叶提取物及其医药和保健用途[P]. 江苏省: CN101011499B, 2011-08-10.

[15]柴程芝, 余伯阳, 朱丹妮, 寇俊萍. 一种治疗痛经的中药组合物及其制备方法[P]. 江苏省: CN101406531B, 2011-07-20.

[16]寇俊萍, 余伯阳, 戚进, 稻垣直树, 朱丹妮. 2-Ο-α-L-鼠李糖-4,6,4′-三羟基二苯甲酮的医药用途[P]. 江苏省: CN101816668B, 2011-07-20.

[17]寇俊萍, 张建宏, 朱丹妮, 戚进, 余伯阳, 严永清. 一种防治心脑血管疾病的中药有效部位组合物及制备方法[P]. 江苏省: CN101028437B, 2011-05-04.

[18]余伯阳, 寇俊萍, 黄娅琳, 蒋文雯, 刘吉华. 一种防治炎症相关心脑血管疾病的药物靶标及其抑制剂[P]. 江苏省: CN101125146B, 2011-05-04.

[19]余伯阳, 蒋文雯, 寇俊萍, 张剑, 卢灯翠. 异喹啉生物碱类作为组织因子抑制剂的医药用途[P]. 江苏省: CN101327214B, 2011-01-12.

[20]寇俊萍, 余伯阳, 戚进, 稻垣直树, 朱丹妮. 2-O-α-L-鼠李糖-4,6,4′-三羟基二苯甲酮的医药用途[P]. 江苏省: CN101439040B, 2011-01-12.

[21]余伯阳, 李仲树, 寇俊萍, 周丽娟. 防治心脑血管疾病的中药组合物[P]. 福建省: CN101129469B, 2010-09-29.

[22]余伯阳, 刘吉华, 蔡金龙, 周祥, 寇俊萍. 一种具有抗氧化衰老作用的功能食品[P]. 江苏省: CN101095521B, 2010-05-12.

[23]余伯阳, 寇俊萍, 张建宏, 朱丹妮, 戚进, 严永清. 一种治疗心脑血管疾病的中药有效成分组合物及其用途[P]. 江苏省: CN100566720C, 2009-12-09.

[24]严永清, 朱丹妮, 林志宏, 寇俊萍, 余伯阳. 一种保健食品及其制备方法[P]. 江苏省: CN100425159C, 2008-10-15.

[25]余伯阳, 张伟, 刘吉华, 严永清, 寇俊萍. 低毒高纯度雄黄的制备方法[P]. 江苏省: CN1302784C, 2007-03-07.

[26]朱丹妮, 余伯阳, 沈平孃, 严永清, 阮克锋, 林志宏, 王鹏, 寇俊萍, 顾维, 周迎新. 一种防治老年痴呆的中药有效部位组合物及其制备方法[P]. 江苏省: CN1225250C, 2005-11-02.

[27]朱丹妮, 寇俊萍, 马仁强, 严永清. 中药黄花倒水莲在制药治疗梅尼埃病药物中的应用[P]. 江苏省: CN1209127C, 2005-07-06.

[28]朱丹妮, 王秋娟, 高山林, 寇俊萍, 徐宏江, 李浩. 黄花倒水莲总皂苷及其药物组合物与制备方法[P]. 江苏省: CN1186351C, 2005-01-26.

[29]严永清, 朱丹妮, 林志宏, 余伯阳, 寇俊萍. 一种防治老年痴呆的中药组合物[P]. 江苏省: CN1160114C, 2004-08-04.

发表英文论文:

1. Xu, Xi; Chang, Xiujin; Huang, Jingxuan; Zhang, Di; Wang, Min; Jing, Tian; Zhuang, Yu; Kou, Junping; Qiu, Zhixia; Wang, Jubo; Li, Zhiyu*; Bian, Jinlei*.Discovery of novel glutaminase 1 allosteric inhibitor with 4-piperidinamine linker and aromatic heterocycles.European Journal of Medicinal Chemistry, 2022, 236: 114337.

2. Xu Xi; Zhang Di; Zhao Tengteng; Wang Min; Li Yu; Du Qianming; Kou Junping; Li Zhiyu; Bian Jinlei.Novel biphenyl-based scaffold as potent and selective histone deacetylase 6 (HDAC6) inhibitors: Identification, development and pharmacological evaluation.European Journal of Medicinal Chemistry, 2022, 233(prepublish).

3. Fu, Fei; Lai, Qiong; Hu, Jingui; Zhang, Lu; Zhu, Xiaozhou; Kou, Junping; Yu, Boyang*; Li, Fang*.Ruscogenin Alleviates Myocardial Ischemia-Induced Ferroptosis through the Activation of BCAT1/BCAT2.Antioxidants, 2022, 11(3): 583.

4. Zhang, Jiazhi; Pan, Ziqian; Zhou, Jianhao; Zhang, Ling; Tang, Jiahui; Gong, Shuaishuai; Li, Fang; Yu, Boyang; Zhang, Yuanyuan*; Kou, Junping*.The myosin II inhibitor, blebbistatin, ameliorates pulmonary endothelial barrier dysfunction in acute lung injury induced by LPS via NMMHC IIA/Wnt5a/beta-catenin pathway.Toxicology and Applied Pharmacology, 2022, 450: 116132.

5. Lai, Qiong; Liu, Fu-Ming; Rao, Wang-Lin; Yuan, Guang-Ying; Fan, Zhao-Yang; Zhang, Lu; Fu, Fei; Kou, Jun-Ping; Yu, Bo-Yang*; Li, Fang*.Aminoacylase-1 plays a key role in myocardial fibrosis and the therapeutic effects of 20(S)-ginsenoside Rg3 in mouse heart failure.Acta Pharmacologica Sinica, 2022, 43(8): 2003-2015.

6. Su, Lin-Jie; Ren, Yu-Chuan; Chen, Zhuo; Ma, Hui-Fen; Zheng, Fan; Li, Fang; Zhang, Yuan-Yuan; Gong, Shuai-Shuai*; Kou, Jun-Ping*.Ginsenoside Rb1 improves brain, lung, and intestinal barrier damage in middle cerebral artery occlusion/reperfusion (MCAO/R) mice via the PPAR gamma signaling pathway.Chinese Journal of Natural Medicines, 2022, 20(8): 561-571.

7. Hu, Jingui; Zhang, Ling; Fu, Fei; Lai, Qiong; Zhang, Lu; Liu, Tao; Yu, Boyang; Kou, Junping*; Li, Fang*.Cardioprotective effect of ginsenoside Rb1 via regulating metabolomics profiling and AMP-activated protein kinase-dependent mitophagy.Journal of Ginseng Research, 2022, 46(2): 255-265.

8. Su, Linjie; Liu, Yining; Ma, Huifen; Zheng, Fan; Daia, Yujie; Wang, Tiezheng; Wang, Guangyun; Li, Fang; Zhang, Yuanyuan; Yu, Boyang; Gong, Shuaishuai*; Kou, Junping*.YiQiFuMai lyophilized injection attenuates cerebral ischemic injury with inhibition of neuronal autophagy through intervention in the NMMHC IIA-actin-ATG9A interaction.Phytomedicine, 2022, 95: 153882.

9. Ma, Hui-fen; Zheng, Fan; Su, Lin-jie; Zhang, Da-wei; Liu, Yi-ning; Li, Fang; Zhang, Yuan-yuan; Gong, Shuai-shuai*; Kou, Jun-Ping*.Metabolomic Profiling of Brain Protective Effect of Edaravone on Cerebral Ischemia-Reperfusion Injury in Mice.Frontiers in Pharmacology, 2022, 13: 814942.

10. Xu, Xi; Wang, Jubo; Wang, Min; Yuan, Xinyu; Li, Lei; Zhang, Chao; Huang, Huidan*; Jing, Tian; Wang, Chenchen; Tong, Chao; Zhou, Liwen; Meng, Ying; Xu, Pengfei; Kou, Junping; Qiu, Zhixia; Li, Zhiyu*; Bian, Jinlei*.Structure-Enabled Discovery of Novel Macrocyclic Inhibitors Targeting Glutaminase 1 Allosteric Binding Site.Journal of Medicinal Chemistry, 2021, 64(8): 4588-4611.

11. Liu, Yuankai; Dai, Yujie; Xu, Han; Zhou, Qianliu; Li, Fang; Yu, Boyang; Zhang, Yuanyuan*; Kou, Junping*.YQFM Alleviates Side Effects Caused by Dasatinib through the ROCK/MLC Pathway in Mice.Evidence-Based Complementary and Alternative Medicine, 2020, 2020: 4646029.

12. Wu, Yunhao; Wang, Yuwei; Gong, Shuaishuai; Tang, Jiahui; Zhang, Jiazhi; Li, Fang; Yu, Boyang; Zhang, Yuanyuan*; Kou, Junping*.Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by suppressing TLR4 signaling.Biomedicine & Pharmacotherapy, 2020, 125: 109868.

13. Lai, Qiong; Yuan, Guangying; Wang, Hao; Liu, Zeliang; Kou, Junping; Yu, Boyang*; Li, Fang*.Metabolomic profiling of metoprolol-induced cardioprotection in a murine model of acute myocardial ischemia.Biomedicine & Pharmacotherapy, 2020, 124: 109820.

14. Pan, Xue-wei; Wang, Mei-juan; Gong, Shuai-shuai; Sun, Min-hui; Wang, Yan; Zhang, Yuan-yuan; Li, Fang; Yu, Bo-yang; Kou, Jun-Ping*.YiQiFuMai Lyophilized Injection ameliorates tPA-induced hemorrhagic transformation by inhibiting cytoskeletal rearrangement associated with ROCK1 and NF-kappa B signaling pathways.Journal of Ethnopharmacology, 2020, 262: 113161.

15. Song, Xianrui; Gong, Zixuan; Liu, Kaili; Kou, Junping; Liu, Baolin; Liu, Kang.Baicalin combats glutamate excitotoxicity via protecting glutamine synthetase from ROS-induced 20S proteasomal degradation.Redox Biology, 2020, 34: 101559.

16. Lai, Qiong; Yuan, Guang-ying; Wang, Hao; Liu, Ze-liang; Kou, Jun-Ping; Yu, Bo-yang*; Li, Fang*.Exploring the protective effects of schizandrol A in acute myocardial ischemia mice by comprehensive metabolomics profiling integrated with molecular mechanism studies.Acta Pharmacologica Sinica, 2020, 41(8): 1058-1072.

17. Zhang, Yuanyuan; Hu, Yang; Li, Min; Wang, Jieman; Guo, Gengshuo; Li, Fang; Yu, Boyang*; Kou, Junping*.The Traditional Chinese Medicine Compound, GRS, Alleviates Blood-Brain Barrier Dysfunction.Drug Design, Development and Therapy, 2020, 14: 933-946.

18. Wang, Guang-Yun; Wang, Tie-Zheng; Zhang, Yuan-Yuan; Li, Fang; Yu, Bo-Yang; Kou, Jun-Ping*.NMMHC IIA Inhibition Ameliorates Cerebral Ischemic/Reperfusion-Induced Neuronal Apoptosis Through Caspase-3/ROCKI/MLC Pathway.Drug Design, Development and Therapy, 2020, 14: 13-25.

19. Zhang, Yuanyuan; Zhao, Yazheng; Wu, Yan; Qi, Jin; Li, Fang; Kou, Junping*; Yu, Boyang*.Ophiopogon Saponin C1 Inhibits Lung Tumors by Stabilizing Endothelium Permeability via Inhibition of PKC delta.International Journal of Biological Sciences, 2020, 16(3): 396-407.

20. Wang, Guangyun; Wang, Tiezheng; Zhang, Yuanyuan; Li, Fang; Yu, Boyang; Kou, Junping*.Schizandrin Protects against OGD/R-Induced Neuronal Injury by Suppressing Autophagy: Involvement of the AMPK/mTOR Pathway.Molecules, 2019, 24(19): 3624.

21. Zhang, Yu; Zhang, Ling; Zhang, Yan; Fan, Xiaoxue; Yang, Weiwei; Yu, Boyang; Kou, Junping*; Li, Fang*.YiQiFuMai Powder Injection Attenuates Coronary Artery Ligation-Induced Heart Failure Through Improving Mitochondrial Function via Regulating ROS Generation and CaMKII Signaling Pathways.Frontiers in Pharmacology, 2019, 10: 381.

22. Li, Fang; Pang, Li Zhi; Zhang, Ling; Zhang, Yu; Zhang, Yuan Yuan; Yu, Bo Yang; Kou, Jun Ping*.YiQiFuMai powder injection ameliorates chronic heart failure through cross-talk between adipose tissue and cardiomyocytes via up-regulation of circulating adipokine omentin.Biomedicine & Pharmacotherapy, 2019, 119: UNSP 109418.

23. Badamjav, Rentsen; Sonom, Dolgor; Wu, Yunhao; Zhang, Yuanyuan; Kou, Junping; Yu, Boyang*; Li, Fang*.The protective effects of Thalictrum minus L. on lipopolysaccharide-induced acute lung injury.Journal of Ethnopharmacology, 2019, 248: 112355.

24. Zhang, Yu; Zhang, Ling; Fan, Xiaoxue; Yang, Weiwei; Yu, Boyang; Kou, Junping*; Li, Fang*.Captopril attenuates TAC-induced heart failure via inhibiting Wnt3a/beta-catenin and Jak2/Stat3 pathways.Biomedicine & Pharmacotherapy, 2019, 113: 108780.

25. Zhou, Peipei; Yang, Xiaolin; Yang, Zhonglin; Huang, Wenzhe; Kou, Junping*; Li, Fei*.Akebia Saponin D Regulates the Metabolome and Intestinal Microbiota in High Fat Diet-Induced Hyperlipidemic Rats.Molecules, 2019, 24(7).

26. Zhou, Kecheng; Chen, Jie; Wu, Jiayu; Wu, Qiaoyun; Jia, Chengqian; Xu, Yang Xin Zi; Chen, Liang; Tu, Wenzhan; Yang, Guanhu; Kong, Jiming*; Kou, Junping*; Jiang, Songhe*.Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in microglia.Phytomedicine, 2019, 59: 152922.

27. Peng, Shuang; Wang, Yilei; Zhou, Ying; Ma, Tingting; Wang, Yapu; Li, Jia; Huang, Fang; Kou, Junping; Qi, Lianwen; Liu, Baolin; Liu, Kang*.Rare ginsenosides ameliorate lipid overload-induced myocardial insulin resistance via modulating metabolic flexibility (vol 58, 152745, 2019).Phytomedicine, 2019, 61: UNSP 152989.

28. Fan, Yunshi; Lu, Mi; Yu, Xie an; He, Miaoling; Zhang, Yu; Ma, Xiao Nan; Kou, Junping; Yu, Bo Yang*; Tian, Jiangwei*.Targeted Myocardial Hypoxia Imaging Using a Nitroreductase-Activatable Near-Infrared Fluorescent Nanoprobe.Analytical Chemistry, 2019, 91(10): 6585-6592.

29. Zhang, Yuanyuan; Liu, Mingchuan; Fan, Ruiping; Zhou, Qianliu; Yang, Jinping; Yang, Shengjie; Wang, Chaojih*; Kou, Junping*.Walnut protein isolates attenuate particulate matter-induced lung and cardiac injury in mice and zebra fish.RSC Advances, 2019, 9(69): 40736-40744.

30. Liu, Mingchuan; Yang, Shengjie; Yang, Jinping; Lee, Yita; Kou, Junping*; Wang, Chaojih*.Neuroprotective and Memory-Enhancing Effects of Antioxidant Peptide From Walnut (Juglans regia L.) Protein Hydrolysates.Natural Product Communications, 2019, 14(7).

31. Peng, Shuang; Wang, Yilei; Zhou, Ying; Ma, Tingting; Wang, Yapu; Li, Jia; Huang, Fang; Kou, Junping; Qi, Lianwen; Liu, Baolin; Liu, Kang*.Rare ginsenosides ameliorate lipid overload-induced myocardial insulin resistance via modulating metabolic flexibility.Phytomedicine, 2019, 58: 152745.

32. Fan, Ruiping; Han, Yuwei; Han, Han; Chen, Zhengdong; Yu, Boyang; Kou, Junping*; Zhang, Yuanyuan*.DT-13 ameliorates TNF-alpha-induced nitric oxide production in the endothelium in vivo and in vitro.Biochemical and Biophysical Research Communications, 2018, 495(1): 1175-1181.

33. Li, Fang; Fan, Xiao-Xue; Chu, Chun; Zhang, Yu; Kou, Jun-Ping*; Yu, Bo-Yang*.A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia.Cellular Physiology and Biochemistry, 2018, 45(4): 1455-1471.

34. Zhang Yuanyuan; Han Yuwei; Zhao Yazheng; Lv Yanni; Hu Yang; Tan Yisha; Bi Xueyuan; Yu Boyang; Kou Junping.DT-13 Ameliorates TNF-alpha-Induced Vascular Endothelial Hyperpermeability via Non-Muscle Myosin IIA and the Src/PI3K/Akt Signaling Pathway.Frontiers in Immunology, 2017, 8: 925.

35. Xu, Yingqiong; Wang, Yan; Wang, Guangyun; Ye, Xinyi; Zhang, Jiangwei; Cao, Guosheng; Zhao, Yazheng; Gao, Zhen; Zhang, Yuanyuan; Yu, Boyang*; Kou, Junping*.YiQiFuMai Powder Injection Protects against Ischemic Stroke via Inhibiting Neuronal Apoptosis and PKC delta/Drp1-Mediated Excessive Mitochondrial Fission.Oxidative Medicine and Cellular Longevity, 2017, 2017: 1832093.

36. Fan Xiao Xue; Li Fang; Lv Yan Ni; Zhang Yu; Kou, Jun Ping*; Yu Bo Yang*.An integrated shotgun proteomics and bioinformatics approach for analysis of brain proteins from MCAO model using serial affinity chromatograph with four active ingredients from Shengmai preparations as ligands.Neurochemistry International, 2017, 103: 45-56.

37. Sun Lan; Liu Li Na; Li Jia Chun; Lv Yao Zhong; Zong Shao Bo; Zhou Jun; Wang Zheng Zhong; Kou, Jun Ping*; Xiao Wei*.The essential oil from the twigs of Cinnamomum cassia Presl inhibits oxytocin-induced uterine contraction in vitro and in vivo.Journal of Ethnopharmacology, 2017, 206: 107-114.

38. Yang Ye; Tian Yushan; Hu Siyao; Bi Suxia; Li Suxia; Hu Yuanjia; Kou Junping; Qi Jin*; Yu Boyang*.Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca2 -Calcineurin-Mediated Drp1 Signaling Pathways.International Journal of Molecular Sciences, 2017, 18(9): 1825.

39. Li Fang; Zhang Yu; Zeng Donglin; xia Yu; Fan Xiaoxue; Tan Yisha; Kou Junping; Yu Boyang.The Combination of Three Components Derived from Sheng MaiSan Protects Myocardial Ischemic Diseases and Inhibits Oxidative Stress via Modulating MAPKs and JAK2-STAT3 Signaling Pathways Based on Bioinformatics Approach.Frontiers in Pharmacology, 2017, 8: 21.

40. Wang Yan; Xu Yingqiong; Liu Qian; Zhang Yuanyuan; Gao Zhen; Yin Mingzhu; Jiang Nan; Cao Guosheng; Yu Boyang; Cao Zhengyu; Kou Junping.Myosin IIA-related Actomyosin Contractility Mediates Oxidative Stress-induced Neuronal Apoptosis.Frontiers in Molecular Neuroscience, 2017, 10: 75.

41. Zhai Ke feng; Zheng Jin rong; Tang You mei; Li Fang; Lv Yan ni; Zhang Yuan yuan; Gao Zhen; Qi Jin; Yu Bo yang*; Kou, Jun Ping*.The saponin D39 blocks dissociation of non-muscular myosin heavy chain IIA from TNF receptor 2, suppressing tissue factor expression and venous thrombosis.British Journal of Pharmacology, 2017, 174(17): 2818-2831.

42. Zhang Yuanyuan; Li Long; Zhao Yazheng; Han Han; Hu Yang; Liang Di; Yu Boyang; Kou Junping*.The Myosin II Inhibitor, Blebbistatin, Ameliorates FeCl3-induced Arterial Thrombosis via the GSK3 beta-NF-kappa B Pathway.International Journal of Biological Sciences, 2017, 13(5): 630-639.

43. Pang Li zhi; Ju Ai chun; Zheng Xian jie; Li Fang; Song Yun fei; Zhao Yan; Gu Yuan feng; Chen Fei leng; Liu Chun Hua; Qi Jin; Gao Zhen; Kou, Jun Ping*; Yu Bo yang*.YiQiFuMai Powder Injection attenuates coronary artery ligation-induced myocardial remodeling and heart failure through modulating MAPKs signaling pathway.Journal of Ethnopharmacology, 2017, 202: 67-77.

44. Mi, Jia Ning; Han, Yuwei; Xu, Yingqiong; Kou, Junping; Wang, Jing Rong*; Jiang, Zhi Hong*.New Immunosuppressive Sphingoid Base and Ceramide Analogues in Wild Cordyceps.Scientific Reports, 2016, 6(1): 38641.

45. Kou, Jun Ping.Analgesic Effects of Danggui-Shaoyao-San on Various “Phenotypes” of Nociception and Inflammation in a Formalin Pain Model.Molecular Neurobiology, 2016, 53(10): 6835-6848.

46. Chen Hong Lin; Zhao Jing; Zhang Guan Jun; Kou, Jun Ping*; Yu Bo Yang.An optimized micro-assay of myosin II ATPase activity based on the molybdenum blue method and its application in screening natural product inhibitors.Chinese Journal of Natural Medicines, 2016, 14(6): 421-426.

47. Cao Guosheng; Zhou Huana; Jiang Nan; Han Yuwei; Hu Yang; Zhang Yuanyuan; Qi Jin; Kou Junping*; Yu Boyang.YiQiFuMai Powder Injection Ameliorates Cerebral Ischemia by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis.Oxidative Medicine and Cellular Longevity, 2016, 2016: 5493279.

48. Sun Lan; Zong Shao Bo; Li Jia Chun; Lv Yao Zhong; Liu Li Na; Wang Zheng Zhong; Zhou Jun; Cao Liang; Kou, Jun Ping*; Xiao Wei*.The essential oil from the twigs of Cinnamomum cassia Presl alleviates pain and inflammation in mice.Journal of Ethnopharmacology, 2016, 194: 904-912.

49. Chai Cheng Zhi; Mo Wei Lan; Zhuang Xian Fei; Kou, Jun Ping; Yan Yong Qing; Yu Bo Yang*.Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice.Evidence-Based Complementary and Alternative Medicine, 2016, 2016: 4682786.

50. Cao Guosheng; JIang Nan; Hu Yang; Zhang Yuanyuan; Li Fang; Liu Chunhua; Xiang Xiang; Qi Jin; Chai Chengzhi; Kou Junping*; Yu Boyangyang.YiQiFuMai Powder Injection ameliorates the oxygen-glucose deprivation-induced brain microvascular endothelial barrier dysfunction associated with the NF-κB and ROCK1/MLC signaling pathways.Journal of Ethnopharmacology, 2016, 183(1): 18-28.

51. Cao Guosheng; JIang Nan; Hu Yang; Zhang Yuanyuan; Wang Guangyun; Yin Mingzhu; Ma Xiaonan; Zhou Kecheng; Qi Jin; Yu Boyang*; Kou Junping*.Ruscogenin attenuates cerebral ischemia-induced blood-brain barrier dysfunction by suppressing TXNIP/NLRP3 inflammasome activation and the MAPK pathway.International Journal of Molecular Sciences, 2016, 17(9): 1418.

52. Kou, Jun Ping.YiQiFuMai Powder Injection Ameliorates Cerebral Ischemia by Inhibiting Endoplasmic Reticulum.Oxidative Medicine and Cellular Longevity, 2016, 1(14): 1-14.

53. Li Yi; Zhou Zhi Hui; Chen Mei Hong; Yang Jie; Leng Jing; Cao Guo Sheng; Xin Gui Zhong; Liu Li Fang; Kou, Jun Ping; Liu Bao Lin; Li Ping; Wen Xiao Dong*.Inhibition of Mitochondrial Fission and NOX2 Expression Prevent NLRP3 Inflammasome Activation in the Endothelium: The Role of Corosolic Acid Action in the Amelioration of Endothelial Dysfunction.Antioxidants and Redox Signaling, 2016, 24(16): 893-908.

54. Shen Jinyang; Bi Jianping; Tian Hongli; Jin Ye; Wang Yuan; Yang Xiaolin; Yang Zhonglin; Kou Junping; Li Fei.Preparation and evaluation of a self-nanoemulsifying drug delivery system loaded with Akebia saponin D-phospholipid complex.International Journal of Nanomedicine, 2016, 11: 4919-4929.

55. Kou, Jun Ping.YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice.Drug Des Devel Ther, 2016, 10(5): 315-325.

56. Sun Lan; Liu Lina; Zong Shaobo; Wang Zhengzhong; Zhou Jun; Xu Zhiliang; Ding Gang; Xiao Wei*; Kou Junping*.Traditional Chinese medicine Guizhi Fuling capsule used for therapy of dysmenorrhea via attenuating uterus contraction.Journal of Ethnopharmacology, 2016, 191: 273-279.

57. Yu Xiu; Yu Sulan; Chen Ling; Liu Han; Zhang Jian; Ge Haixia; Zhang Yuanyuan; Yu Boyang*; Kou Junping*.Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-kappa B signaling pathways.Biomedicine & Pharmacotherapy, 2016, 82: 489-497.

58. Yang Lu; Chai Cheng Zhi; Yue Xin Yi; Yan Yan; Kou, Jun Ping; Cao Zheng Yu*; Yu Bo Yang*.Ge-Gen Decoction attenuates oxytocin-induced uterine contraction and writhing response: potential application in primary dysmenorrhea therapy.Chinese Journal of Natural Medicines, 2016, 14(2): 124-132.

59. Liu Chunhua; Ju Aichun; Zhou Dazheng; Li Dekun; Kou Junping; Yu Boyang*; Qi Jin*.Simultaneous Qualitative and Quantitative Analysis of Multiple Chemical Constituents in YiQiFuMai Injection by Ultra-Fast Liquid Chromatography Coupled with Ion Trap Time-of-Flight Mass Spectrometry.Molecules, 2016, 21(5): 640.

60. Chen Gangling; Ye Xinyi; Zhang Jiangwei; Tang Tingli; Li Lin; Lu Peirong; Wu Qi; Yu Boyang*; Kou Junping*.Limb Remote Ischemic Postconditioning Reduces Ischemia-Reperfusion Injury by Inhibiting NADPH Oxidase Activation and MyD88-TRAF6-P38MAP-Kinase Pathway of Neutrophils.International Journal of Molecular Sciences, 2016, 17(12): 1971.

61. Kou, Jun Ping.Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.Oncotarget, 2016, 7(19): 27552-27566.

62. Kou, Jun Ping.Cardioprotection by combination of three compounds from ShengMai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission.Scientific Reports, 2016, 6(37114).

63. Chen Yan; Xu Xiaoshan; Zhang Yuanyuan; Liu Kang; Huang Fang; Liu Baolin*; Kou Junping.Diosgenin regulates adipokine expression in perivascular adipose tissue and ameliorates endothelial dysfunction via regulation of AMPK.Journal of Steroid Biochemistry and Molecular Biology, 2016, 155: 155-165.

64. Li Xiaole; Li Jia; Wang Lulu; Li Aiyun; Qiu Zhixia; Qi Lian wen; Kou Junping; Liu Kang; Liu Baolin; Huang Fang*.The role of metformin and resveratrol in the prevention of hypoxia-inducible factor 1 accumulation and fibrosis in hypoxic adipose tissue.British Journal of Pharmacology, 2016, 173(12): 2001-2015.

65. Wang Yan; Liu Qian; Xu Yingqiong; Zhang Yuanyuan; Lv Yanni; Tan Yisha; Jiang Nan; Cao Guosheng; Ma Xiaonan; Wang Jingrong; Cao Zhengyu; Yu Boyang*; Kou Junping*.Ginsenoside Rg1 Protects against Oxidative Stress-induced Neuronal Apoptosis through Myosin IIA-actin Related Cytoskeletal Reorganization.International Journal of Biological Sciences, 2016, 12(11): 1341-1356.

66. Kou, Jun Ping.Tetrahydroberberrubine attenuates lipopolysaccharide-induced acute lung injury by down-regulating MAPK, AKT, and NF-kB signaling pathways.Biomedicine & Pharmacotherapy, 2016, 82(2): 489-497.

67. Li Fang; Zheng Xianjie; Fan Xiaoxue; Zhai Kefeng; Tan Yisha; Kou Junping*; Yu Boyang*.YiQiFuMai Powder Injection Attenuates Ischemia/Reperfusion-Induced Myocardial Apoptosis Through AMPK Activation.Rejuvenation Research, 2016, 19(6): 495-508.

68. Yang Haopeng; Li Long; Zhou Kecheng; Wang Yuqing; Guan Teng; Chai Chengzhi; Kou Junping*; Yu Boyang; Yan Yongqing.Shengmai injection attenuates the cerebral ischemia/reperfusion induced autophagy via modulation of the AMPK, mTOR and JNK pathways.Pharmaceutical Biology, 2016, 54(10): 2288-2297.

69. Liu Kang; Mei Fan; Wang Yapu; Xiao Na; Yang Lele; Wang Yilei; Li Jia; Huang Fang; Kou Junping; Liu Baolin; Qi Lian Wen*.Quercetin oppositely regulates insulin-mediated glucose disposal in skeletal muscle under normal and inflammatory conditions: The dual roles of AMPK activation.Molecular Nutrition & Food Research, 2016, 60(3): 551-565.

70. Yin Ming zhu; Tan Shu; Li Xia; Hou Yan; Cao Guosheng; Li Kang*; Kou Junping*; Lou Ge*.Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.Tumor Biology, 2016, 37(4): 5485-5492.

71. Cao Guo Sheng; Li Shao Xia; Wang Yan; Xu Ying Qiong; Lv Yan Ni; Kou, Jun Ping*; Yu Bo Yang.A combination of four effective components derived from Sheng-mai san attenuates hydrogen peroxide-induced injury in PC12 cells through inhibiting Akt and MAPK signaling pathways.Chinese Journal of Natural Medicines, 2016, 14(7): 508-517.

72. Chen HL; Zhao J; Zhang GJ; Kou JP*; Yu BY.An optimized micro-assay of myosin II ATPase activity based on the molybdenum blue method and its application in screening natural product inhibitors.Chinese Journal of Natural Medicines, 2016, 14(6): 421-426.

73. Zhang Yuanyuan; Sun Minhui; Han Yuwei; Zhai Kefeng; Tang Youmei; Qin Xiaoying; Cao Zhengyu; Yu Boyang*; Kou Junping.The saponin DT-13 Attenuates Tumor Necrosis Factor-alpha-induced Vascular Inflammation Associated with Src/NF-kappa B/MAPK Pathway Modulation.International Journal of Biological Sciences, 2015, 11(8): 970-981.

74. Li Yong Wei; Qi Jin; Zhang Yuan Yuan; Huang Zhen; Kou, Jun Ping; Zhou Shui Ping; Zhang Yu; Yu Bo Yang*.Novel cytotoxic steroidal glycosides from the roots of Liriope muscari.Chinese Journal of Natural Medicines, 2015, 13(6): 461-466.

75. Kou, Jun Ping.Diosgenin regulates adipokine expression in perivascular adipose tissue and ameliorates endothelial dysfunction via regulation of AMPK.Journal of Steroid Biochemistry and Molecular Biology, 2015, 155: 155-165.

76. Kou, Jun Ping.Cocktail of Four Active Components Derived from Sheng Mai San Inhibits Hydrogen Peroxide-Induced PC12 Cell Apoptosis Linked with the Caspase-3/ROCK1/MLC Pathway.Rejuvenation Research, 2015, 18(6): 517-527.

77. Lin Y N; Jia R; Liu Y H; Gao Y; Wang L L; Kou J P*; Yu B Y.Ruscogenin suppresses mouse neutrophil activation: Involvement of protein kinase A pathway.Journal of Steroid Biochemistry and Molecular Biology, 2015, 154: 85-93.

78. Li Fang; Lv Yan ni; Tan Yi sha; Shen Kai; Zhai Ke feng; Chen Hong lin; Kou, Jun Ping*; Yu Bo yang.An integrated pathway interaction network for the combination of four effective compounds from ShengMai preparations in the treatment of cardio-cerebral ischemic diseases.Acta Pharmacologica Sinica, 2015, 36(11): 1337-1348.

79. Li Jia; Wang Yilei; Wang Yapu; Wen Xiaodong; Ma Xiao Nan; Chen Weijie; Huang Fang; Kou Junping; Qi Lian Wen; Liu Baolin; Liu Kang*.Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction.Journal of Molecular and Cellular Cardiology, 2015, 86: 62-74.

80. Chen Y; Tang YM; Yu SL; Han YW; Kou JP*; Liu BL; Yu BY.Advances in the pharmacological activities and mechanisms of diosgenin.Chinese Journal of Natural Medicines, 2015, 13(8): 578-587.

81. Zhai KF; Tang YM; Zhang YY; Li F; Wang Y; Cao ZY; Yu J; Kou JP*; Yu BY.Non-muscle myosin heavy chain IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3β-NF-κB signaling pathways in the endothelium.Thrombosis and Haemostasis, 2015, 114(1): 173-185.

82. Zhang YY; Han YW; Zhai KF; Sun MH; Liu JH; Yu BY; Kou JP.Ophiopogonin D suppresses MDA MB 435 cell adhesion and invasion by inhibiting matrix metalloproteinase 9.Molecular Medicine Reports, 2015, 12(5): 1493-1498.

83. Zhai Kefeng; Tang Youmei; Zhang Yuanyuan; Li Fang; Wang Yan; Cao Zhengyu; Yu Jun; Kou Junping*; Yu Boyang.NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3 beta-NF-kappa B signalling pathways in the endothelium.Thrombosis and Haemostasis, 2015, 114(1): 173-185.

84. Shen Jin Yang; Yang Xiao Lin; Yang Zhong Lin; Kou, Jun Ping; Li Fei*.Enhancement of absorption and bioavailability of echinacoside by verapamil or clove oil.Drug Design, Development and Therapy, 2015, 9: 4685-4693.

85. Mo W L*; Chai C Z; Kou J P; Yan Y O; Yu B Y.Sheng-Mai-San attenuates contractile dysfunction and structural damage induced by chronic intermittent hypoxia in mice.Chinese Journal of Natural Medicines, 2015, 13(10): 743-750.

86. Fang Li; Yi-Sha Tan; Hong-Lin Chen; Yan Yan; Ke-Feng Zhai; Da-Peng Li; Jun-Ping Kou; Bo-Yang Yu.Identification of schisandrin as a vascular endothelium protective component in YiQiFuMai Powder Injection using HUVECs binding and HPLC-DAD-Q-TOF-MS/MS analysis.Journal of Pharmacological Sciences, 2015.

87. Zhou Kecheng; Jia Nati; Jiang Nan; Wang Feng; Kou Junping*.Beneficial effect of Danggui-Shaoyao-San, a traditional Chinese medicine, on drowsiness induced by chronic restraint stress.Neuroscience Letters, 2015, 597: 26-31.

88. Zhang YY; Sun MH; Han YW; Zhai KF; Tang YM; Qin XY; Cao ZY; Yu BY*; Kou JP.The saponin DT-13 Attenuates Tumor Necrosis Factor-α-induced Vascular Inflammation Associated with Src/NF-кB/MAPK Pathway Modulation.International Journal of Biological Sciences, 2015, 11(8): 970-981.

89. Liu H; Yu X; Yu SL; Kou JP*.Molecular mechanisms in lipopolysaccharide-induced pulmonary endothelial barrier dysfunction.International Immunopharmacology, 2015, 29(2): 937-946.

90. Li Hong Shi; Ke Jie; Zhao Gui Zhi; Wu Li An; Kou, Jun Ping; Liu Hong Chen*.Effects of Danggui-Shaoyao-San on the Influence of Spatial Learning and Memory Induced by Experimental Tooth Movement.Chinese Medical Journal, 2015, 128(14): 1948-1955.

91. Sun, Yan; Li, Jia; Xiao, Na; Wang, Meng; Kou, Junping; Qi, Lianwen; Huang, Fang; Liu, Baolin; Liu, Kang*.Pharmacological activation of AMPK ameliorates perivascular adipose/endothelial dysfunction in a manner interdependent on AMPK and SIRT1.Pharmacological Research, 2014, 89: 19-28.

92. Zhang, Hong; Chen, Ling; Kou, Jun-Ping; Zhu, Dan-Ni; Qi, Jin*; Yu, Bo-Yang.Steroidal sapogenins and glycosides from the fibrous roots of Polygonatum odoratum with inhibitory effect on tissue factor (TF) procoagulant activity.Steroids, 2014, 89: 1-10.

93. Lin YN#; Jia R#; Liu YH; Gao Y; Zeng X; Kou JP*; Yu BY*.Diosgenin inhibits superoxide generation in FMLP-activated mouse neutrophils via multiple pathways.Free Radical Research, 2014, 48(12): 1485-1493.

94. Jianjun Wu; Xiaoshan Xu; Yi Li; Junping Kou; Fang Huang; Baolin Liu; Kang Liu.Quercetin, luteolin and epigallocatechin gallate alleviate TXNIP and NLRP3-mediated inflammation and apoptosis with regulation of AMPK in endothelial cells.European Journal of Pharmacology, 2014, 745: 59-68.

95. Gao, Meng-yu; Chen, Ling; Yang, Lu; Yu, Xiu; Kou, Jun-Ping*; Yu, Bo-yang.Berberine inhibits LPS-induced TF procoagulant activity and expression through NF-κB/p65, Akt and MAPK pathway in THP-1 cells.Pharmacological Reports, 2014, 66(3): 480-484.

96. Lv YN; Li SX; Zhai KF; Kou JP*; Yu BY*.Network pharmacology-based prediction and verification of the molecular targets and pathways for schisandrin against cerebrovascular disease.Chinese Journal of Natural Medicines, 2014, 12(4): 251-258.

97. Du, Chen Hui; Zhang, Jian*; Xu, Shao Hua; Wang, Xu Dong; Kou, Jun Ping; Yu, Bo Yang.Exploring the glycosylation capabilities of Gliocladium deliquescens NRRL 1086 on hydroxyl benzophenones.Journal of Molecular Catalysis B: Enzymatic, 2014, 99: 85-88.

98. Guo ZS; Cao GS; Yang HP; Zhou HN; Li L; Cao ZY; Yu BY; Kou JP*.A Combination of Four Active Compounds Alleviates Cerebral Ischemia-Reperfusion Injury in Correlation With Inhibition of Autophagy and Modulation of AMPK/mTOR and JNK Pathways.Journal of Neuroscience Research, 2014, 92(10): 1295-1306.

99. Tan YS; Li F; Lv YN; Zhai KF; Kou JP*; Yu BY*.Study on the multi-targets mechanism of YiQiFuMai Powder Injection on cardio-cerebral ischemic diseases based on network pharmacology.Journal of Proteomics Computational Biology, 2014, 1(1).

100. Yang Hao-Peng; Yue Lei; Jiang Wen-Wen; Liu Qian; Kou Jun-Ping*; Yu Bo-Yang.Diosgenin inhibits tumor necrosis factor-induced tissue factor activity and expression in THP-1 cells via down-regulation of the NF-kappa B, Akt, and MAPK signaling pathways.Chinese Journal of Natural Medicines, 2013, 11(6): 608-615.

101. Gao MY; Chen L; Yu HX; Sun Q; Kou JP*; Yu BY*.Diosgenin down-regulates NF-κB p65/p50 and p38MAPK pathways and attenuates acute lung injury induced by lipopolysaccharide in mice.International Immunopharmacology, 2013, 15(2): 240-245.

102. Tian Youqing; Ma Shengtang; Lin Biqi; Kou Junping; Yu Boyang*.Anti-thrombotic activity of DT-13, a saponin isolated from the root tuber of Liriope muscari.Indian Journal of Pharmacology, 2013, 45(3): 283-285.

103. Lv YN; Lu S; Lu T; Kou JP*; Yu BY*.Homology model of nonmuscle myosin heavy chain IIA and binding mode analysis with its inhibitor blebbistatin.Journal of Molecular Model, 2013, 19(4): 1801-1810.

104. Yang HP; Yue L; Jiang WW; Liu Q; Kou JP*; Yu BY.Diosgenin inhibits tumor necrosis factor-induced tissue factor activity and expression in THP-1 cells via down-regulation of the NF-κB, Akt, and MAPK signaling pathways.Chinese Journal of Natural Medicines, 2013, 11(6): 608-615.

105. Ge, Hai-Xia; Chen, Ling; Zhang, Jian*; Kou, Jun-Ping; Yu, Bo-Yang.Inhibitory effect of curcumin analogs on tissue factor procoagulant activity and their preliminary structure-activity relationships.Medicinal Chemistry Research, 2013, 22(7): 3242-3246.

106. Yu, Qian; Qi, Jin; Yu, Hai-Xiang; Chen, Lin-Lin; Kou, Jun-Ping; Liu, Shou-Jin; Yu, Bo-Yang*.Qualitative and Quantitative Analysis of Phenolic Compounds in the Leaves of Aquilaria sinensis Using Liquid Chromatography-Mass Spectrometry.Phytochemical Analysis, 2013, 24(4): 349-356.

107. Bi, Li-Qing; Zhu, Rong; Kong, Hui; Wu, Su-Ling; Li, Nan; Zuo, Xiang-Rong; Zhou, Su-Ming; Kou, Jun-Ping; Yu, Bo-Yang; Wang, Hong*; Xie, Wei-Ping.Ruscogenin attenuates monocrotaline-induced pulmonary hypertension in rats.International Immunopharmacology, 2013, 16(1): 7-16.

108. Guan T; Liu Q; Qian Y; Yang HP; Kong JM; Kou JP*; Yu BY*.Ruscogenin reduces cerebral ischemic injury via NF-κB-mediated inflammatory pathway in the mouse model of experimental stroke.European Journal of Pharmacology, 2013, 714(1–3): 303-311.

109. Wang, M.; Gao, X. J.; Zhao, W. W.; Zhao, W. J.; Jiang, C. H.; Huang, F.; Kou, J. P.; Liu, B. L.; Liu, K.*.Opposite effects of genistein on the regulation of insulin-mediated glucose homeostasis in adipose tissue.British Journal of Pharmacology, 2013, 170(2): 328-340.

110. Lv, Yanni; Lu, Shuai; Lu, Tao; Kou, Junping*; Yu, Boyang.Homology model of nonmuscle myosin heavy chain IIA and binding mode analysis with its inhibitor blebbistatin.Journal of Molecular Modeling, 2013, 19(4): 1801-1810.

111. Ge, Hai-Xia; Zhang, Jian; Chen, Ling; Kou, Jun-Ping*; Yu, Bo-Yang.Chemical and microbial semi-synthesis of tetrahydroprotoberberines as inhibitors on tissue factor procoagulant activity.Bioorganic & Medicinal Chemistry, 2013, 21(1): 62-69.

112. Sun Q#; Chen L#; Gao MY; Jiang WW; Shao FX; Li JJ; Wang J; Kou JP*; Yu BY*.Ruscogenin inhibits lipopolysaccharide-induced acute lung injury in mice: Involvement of tissue factor, inducible NO synthase and nuclear factor (NF)-κB.International Immunopharmacology, 2012, 12(1): 88-93.

113. Zhang Yuan-Yuan; Liu Ji-Hua*; Kou Jun-Ping; Yu Jun; Yu Bo-Yang.DT-13, a steroidal saponin from Liriope muscari L. H. Bailey, suppresses A549 cells adhesion and invasion by inhibiting MMP-2/9.Chinese Journal of Natural Medicines, 2012, 10(6): 436-440.

114. Song JX; Ma L; Kou JP*; Yu BY*.Diosgenin reduces leukocytes adhesion and migration linked with inhibition of intercellular adhesion molecule-1 expression and NF-κB p65 activation in endothelial cells.Chinese Journal of Natural Medicines, 2012, 10(2): 142-149.

115. Gao, Mengyu; Kou, Junping*.Response to correspondence: “The link between inhibition of nitric oxide metabolite production and reduction of LPS induced lung injury,” by Dr. Michael Eisenhut.International Immunopharmacology, 2012, 14(2): 233-233.

116. Zhang, Yuanyuan; Liu, Jihua; Kou, Junping; Yu, Jun; Yu, Boyang*.DT-13 suppresses MDA-MB-435 cell adhesion and invasion by inhibiting MMP-2/9 via the p38 MAPK pathway.Molecular Medicine Reports, 2012, 6(5): 1121-1125.

117. Huang, Fang; Liu, Kang; Du, Hang; Kou, Junping; Liu, Baolin*.Puerarin attenuates endothelial insulin resistance through inhibition of inflammatory response in an IKKβ/IRS-1-dependent manner.Biochimie, 2012, 94(5): 1143-1150.

118. Liu K; Zhao WW; Gao XJ; Huang F; Kou JP*; Liu BL*.Diosgenin ameliorates palmitate-induced endothelial dysfunction and insulin resistance via blocking IKKβ and IRS-1 pathways.Atherosclerosis, 2012, 223(2): 350-358.

119. Liu, Kang; Luo, Tianjiong; Zhang, Zhongai; Wang, Tao; Kou, Junping; Liu, Baolin; Huang, Fang*.Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.Journal of Ethnopharmacology, 2011, 136(3): 473-479.

120. Jiang WW; Kou JP*; Yuan ST; Sun L; Yu BY*.A Simplified and High-Throughput Chromogenic Assay for Testing Tissue Factor-Dependent Procoagulant Activity.Journal of Biomolecular Screening, 2011, 16(3): 295-302.

121. Chai, Chengzhi; Kou, Junping; Zhu, Danni; Yan, Yongqing; Yu, Boyang*.Mice Exposed to Chronic Intermittent Hypoxia Simulate Clinical Features of Deficiency of both Qi and Yin Syndrome in Traditional Chinese Medicine.Evidence-Based Complementary and Alternative Medicine, 2011, 1-7.

122. Liu Q; Kou JP*; Yu BY*.Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation.Neurochemistry International, 2011, 58(1): 119-125.

123. Xu, Fan; Peng, Daiyin; Tao, Chunlei; Yin, Dengke; Kou, Junping; Zhu, Danni; Yu, Boyang*.Anti-depression effects of Danggui-Shaoyao-San, a fixed combination of Traditional Chinese Medicine, on depression model in mice and rats.Phytomedicine, 2011, 18(13): 1130-1136.

124. Ma ST; Kou JP*; Yu BY.Safety evaluation of steroidal saponin DT-13 isolated from the tuber of Liriope muscari (Decne.) Baily.Food and Chemical Toxicology, 2011, 49(9): 2243-2251.

125. Tian YQ; Kou JP*; Li LZ; Yu BY*.Anti-inflammatory Effects of Aqueous Extract from Radix Liriope muscari and Its Major Active Fraction and Component.Chinese Journal of Natural Medicines, 2011, 9(3): 222-226.

126. Song JX#; Kou JP#; Huang YL; Yu BY*.Ruscogenin Mainly Inhibits Nuclear Factor-kappa B but Not Akt and Mitogen-Activated Protein Kinase Signaling Pathways in Human Umbilical Vein Endothelial Cells.Journal of Pharmacological Sciences, 2010, 113(4): 409-413.

127. Chen, Nai-Dong; Yue, Lei; Zhang, Jian; Kou, Jun-Ping; Yu, Bo-Yang.One unique steroidal sapogenin obtained through the microbial transformation of ruscogenin by Phytophthora cactorum ATCC 32134 and its potential inhibitory effect on tissue factor (TF) procoagulant activity.Bioorganic & Medicinal Chemistry Letters, 2010, 20(14): 4015-4017.

128. Kou Junping; Chani Chengzhi; Gao Zhen; Yu Boyang; Zhu Danni; Yan Yongqing.Hypothesis on the Principle of Danggui-Shaoyao-San (DSS) for Treating Different Diseases via the Histamine H1 Receptor Pathway.Mode Tradit Chin Med Mater Med, 2010, 12(3): 325-330.

129. Liu, Xiangping; Du, Yingxiang; Sun, Wen; Kou, Junping; Yu, Boyang.Study on the interaction of levocetirizine dihydrochloride with human serum albumin by molecular spectroscopy.Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2009, 74(5): 1189-1196.

130. Sun, Wen; Du, Yingxiang; Chen, Jianqiu; Kou, Junping; Yu, Boyang.Interaction between titanium dioxide nanoparticles and human serum albumin revealed by fluorescence spectroscopy in the absence of photoactivation.Journal of Luminescence, 2009, 129(8): 778-783.

131. Jiang, Wenwen; Kou, Junping; Zhang, Zhi; Yu, Boyang.The effects of twelve representative flavonoids on tissue factor expression in human monocytes: Structure-activity relationships.Thrombosis Research, 2009, 124(6): 714-720.

132. Huang, Ya-Lin; Kou, Jun-Ping; Ma, Li; Song, Jia-Xi; Yu, Bo-Yang.Possible Mechanism of the Anti-inflammatory Activity of Ruscogenin: Role of Intercellular Adhesion Molecule-1 and Nuclear Factor-kappa B.Journal of Pharmacological Sciences, 2008, 108(2): 198-205.

133. Wang H; Gao J; Kou J; Zhu D*; Yu B.Anti-inflammatory activities of triterpenoid saponins from Polygala japonica.Phytomedicine, 2008, 15(5): 321-326.

134. Xie, Fan; Zhang, Mian; Zhang, Chao-Feng; Wang, Zheng-Tao; Yu, Bo-Yang; Kou, Jun-Ping.Anti-inflammatory and analgesic activities of ethanolic extract and two limonoids from Melia toosendan fruit.Journal of Ethnopharmacology, 2008, 117(3): 463-466.

135. Zhou, Minhua; Wang, Honggang; Suolangjiba; Kou, Junping; Yu, Boyang.Antinociceptive and anti-inflammatory activities of Aquilaria sinensis (Lour.) Gilg. Leaves extract.Journal of Ethnopharmacology, 2008, 117(2): 345-350.

136. Huang, Ya-Lin; Kou, Jun-Ping; Liu, Ji-Hua; Liu, Nan; Yui, Bo-Yang.Comparison of anti-inflammatory activities of ruscogenin, a major steroidal sapogenin from Radix Ophiopogon japonicus, and its succinylated derivative, RUS-2HS.Drug Development Research, 2008, 69(4): 196-202.

137. Ma, Hong-Yue; Kou, Jun-Ping; Wang, Jing-Rong; Yu, Bo-Yang.Evaluation of the anti-inflammatory and analgesic activities of Liu-Shen-Wan and its individual fractions.Journal of Ethnopharmacology, 2007, 112(1): 108-114.

138. Mu, Lingli; Kou, Junping; Zhu, Danni; Yu, Boyang.Comparison of neuroprotective effects of flavonoids, terpenoids, and their combinations from Ginkgo biloba on ischemia-reperfusion - Injured mice.Pharmaceutical Biology, 2007, 45(9): 728-733.

139. Ma, Hongyue; Kou, Junping; Zhu, Danni; Yan, Yongqing; Yu, Boyang.Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-alpha levels, MDA content and enhancing macrophage phagocytosis.International Immunopharmacology, 2006, 6(8): 1355-1362.

140. Kou, Junping; Si, Minda; Dai, Guofei; Lin, Yuwen; Zhu, Danni.Antiinflammatory activity of Polygala japonica extract.Fitoterapia, 2006, 77(6): 411-415.

141. Kou, JP; Ni, Y; Li, N; Wang, JR; Liu, L; Jiang, ZH.Analgesic and anti-inflammatory activities of total extract and individual fractions of Chinese medicinal ants Polyrhachis lamellidens.Biological & Pharmaceutical Bulletin, 2005, 28(1): 176-180.

142. Kou, JP; Zhu, DN; Yan, YQ.Neuroprotective effects of the aqueous extract of the Chinese medicine Danggui-Shaoyao-san on aged mice.Journal of Ethnopharmacology, 2005, 97(2): 313-318.

143. Kou, JP; Yu, BY; Xu, Q.Inhibitory effects of ethanol extract from Radix Ophiopogon japonicus on venous thrombosis linked with its endothelium-protective and anti-adhesive activities.Vascular Pharmacology, 2005, 43(3): 157-163.

144. Kou, JP; Sun, Y; Lin, YW; Cheng, ZH; Zheng, W; Yu, BY; Xu, Q.Anti-inflammatory activities of aqueous extract from Radix ophiopogon japonicus and its two constituents.Biological & Pharmaceutical Bulletin, 2005, 28(7): 1234-1238.

发表中文期刊论文：

[1]任炫榕, 刘桔, 刘凤, 宫帅帅, 寇俊萍, 宋少江, 于慕湲, 王文静. 斯赤列乙酸乙酯萃取物中的萜类成分及其血管内皮细胞保护活性研究（Ⅰ）[J]. 天然产物研究与开发, 1-15.

[2]朱紫含, 唐嘉辉, 张媛媛, 寇俊萍. 麦门冬饮子通过调控PAR1/Gαi/cAMP信号通路及TRPV1表达改善阴虚肺热咳嗽的作用机制[J]. 中国实验方剂学杂志, 2026, 32 (01): 81-91.

[3]凌雪宇, 张米玲, 徐元昊, 包亮英, 宫帅帅, 寇俊萍. 牛黄清心丸改善痰热腑实型脑出血小鼠血脑屏障损伤的作用机制[J]. 中国实验方剂学杂志, 2025, 31 (24): 39-49.

[4]祁明明, 寇俊萍, 应松言, 王思锦, 魏凯峰. 基于浊邪害清辨治湿热疫逆传心包[J]. 南京中医药大学学报, 2025, 41 (04): 425-430.

[5]李海岚, 朱紫含, 李月, 肖梦雪, 张媛媛, 寇俊萍. 中药活性成分调节脂质代谢改善代谢功能障碍相关脂肪性肝病的研究进展[J]. 中国药科大学学报, 2025, 56 (04): 507-514.

[6]秦响英, 张力元, 唐嘉辉, 岳孟, 寇俊萍, 张媛媛. 血必净注射液干预cGAS/STING通路对脓毒症急性肺损伤的改善作用[J]. 中国药科大学学报, 2025, 56 (03): 350-357.

[7]张米玲, 包亮英, 代玉洁, 宫帅帅, 寇俊萍. 牛黄清心丸及其活性成分防治脑中风的研究进展[J]. 中国实验方剂学杂志, 2024, 30 (18): 251-259.

[8]黄娟, 张米玲, 余俊河, 宫帅帅, 寇俊萍. tPA溶栓引起的出血性转化机制及小分子化合物干预作用研究进展[J]. 药学研究, 2024, 43 (04): 384-390+401.

[9]吴丛宇, 周悦, 上官璐茜, 杨雅妮, 王晶雅, 余俊河, 宫帅帅, 寇俊萍. 大黄素的药理作用机制研究进展[J]. 中国药科大学学报, 2023, 54 (05): 634-643.

[10]张培培, 陈晶鑫, 张阿玉, 寇俊萍, 黄芳. 中药学类本科生贯通性实验设计与实践的探索[J]. 时珍国医国药, 2023, 34 (10): 2527-2529.

[11]吴斌, 曹国胜, 陈林霖, 寇俊萍. 经典名方参附方活性成分的药理作用及临床应用研究进展[J]. 湖北中医杂志, 2022, 44 (12): 51-54.

[12]王冠, 顾东蕾, 黄浩然, 苏凇娴, 寇俊萍. 基于复杂网络的抗新冠中药组方中国专利申请研究[J]. 中国发明与专利, 2021, 18 (11): 21-27.

[13]潘雪薇, 薛漓轩, 张佳智, 代玉洁, 李芳, 张媛媛, 寇俊萍. 注射用益气复脉（冻干）对脓毒症诱导小鼠急性肺损伤的改善作用研究[J]. 中国中医急症, 2021, 30 (07): 1129-1133+1168.

[14]陈卓, 宫帅帅, 任玉川, 寇俊萍. 中药改善多器官功能障碍综合征的研究进展[J]. 药学研究, 2021, 40 (07): 470-475.

[15]张三利, 盛明月, 吴琪, 陈逊, 俞妍, 寇俊萍, 陈刚领. 鲁斯可皂苷元对脑缺血再灌注损伤小鼠时钟基因的调控作用[J]. 中国药理学与毒理学杂志, 2021, 35 (07): 502-506.

[16]黄柳绿, 梅杰, 潘立, 王慧敏, 李芳, 张媛媛, 寇俊萍, 余伯阳. 苏打水降尿酸作用的研究[J]. 现代食品, 2020, (22): 164-169+173.

[17]周钱留, 刘元恺, 张媛媛, 寇俊萍. 口服抗血栓药物的不良反应及毒副作用研究进展[J]. 药学研究, 2020, 39 (09): 525-530+535.

[18]殷昆昆, 勾向博, 万梅绪, 张燕欣, 李德坤, 寇俊萍, 鞠爱春. 生脉方治疗心力衰竭的药理作用研究进展[J]. 药物评价研究, 2020, 43 (08): 1501-1505.

[19]马仁强, 颜乙平, 严科池, 寇俊萍, 朱孝云, 张灿锐. 奥希替尼氘代物对EGFR不同表达水平癌细胞的药理活性研究[J]. 中南药学, 2020, 18 (05): 785-789.

[20]马仁强, 杨忠奇, 寇俊萍, 余伯阳. 防治慢性心衰的中药新研发思路与技术要点分析[J]. 中国中药杂志, 2020, 45 (11): 2720-2724.

[21]徐晗, 张媛媛, 寇俊萍. 药源性胃肠道出血及其病理机制的研究进展[J]. 中国药科大学学报, 2019, 50 (06): 659-665.

[22]薛漓轩, 周钱留, 张媛媛, 寇俊萍. 中药活性成分防治脓毒症的研究进展[J]. 药学研究, 2019, 38 (06): 311-317+325.

[23]翟硕, 李娜, 陈蓓宁, 寇俊萍, 邢为藩, 张评浒. 水飞蓟在治疗慢性肝炎中的研究进展[J]. 中国临床药理学与治疗学, 2019, 24 (05): 573-579.

[24]王美娟, 潘雪薇, 张媛媛, 李芳, 寇俊萍. 中药治疗出血性脑卒中的研究进展[J]. 中国实验方剂学杂志, 2019, 25 (17): 226-234.

[25]韩晗, 张媛媛, 潘立, 陈正东, 薛漓轩, 余伯阳, 寇俊萍. 中药有效成分防治骨性关节炎的研究进展[J]. 中国药科大学学报, 2018, 49 (03): 279-285.

[26]濮社班, 王磊, 秦民坚, 张勉, 朱艳, 寇俊萍, 冯锋, 余伯阳. 中药认知型实践教学体系的构建[J]. 药学教育, 2018, 34 (02): 54-57.

[27]胡洋, 张媛媛, 李芳, 王洁熳, 寇俊萍. 中药有效成分调节细胞骨架功能的研究进展[J]. 药学研究, 2018, 37 (04): 187-193.

[28]徐颖琼, 周科成, 赵亚铮, 叶心怡, 寇俊萍. 线粒体融合与分裂在中枢神经系统疾病中的研究进展[J]. 现代生物医学进展, 2018, 18 (07): 1392-1396.

[29]夏远利, Dolgor.S, 吴云皓, 姜思宇, 薛漓轩, 张媛媛, 寇俊萍. 注射用益气复脉(冻干)改善脂多糖诱导小鼠急性肺损伤作用研究[J]. 药物评价研究, 2018, 41 (03): 372-379.

[30]叶心怡, 陈刚领, 刘晗, 赵亚铮, 寇俊萍. 中性粒细胞NADPH氧化酶与组织缺血再灌注关系的研究进展[J]. 现代生物医学进展, 2017, 17 (32): 6380-6385.

[31]赵亚铮, 张媛媛, 寇俊萍, 余伯阳. 紧密连接在肿瘤转移中的作用研究进展[J]. 海峡药学, 2017, 29 (11): 1-5.

[32]李龙, 寇俊萍. 动脉血栓相关治疗靶点及新药研究进展[J]. 中国药科大学学报, 2017, 48 (03): 251-258.

[33]韩雨薇, 张媛媛, 赖秀英, 刘晗, 寇俊萍. 中药对一氧化氮合酶/一氧化氮系统调节作用的研究进展[J]. 中国药科大学学报, 2017, 48 (01): 8-15.

[34]姜楠, 周科成, 寇俊萍. 中药有效成分调控NLRP3炎症小体活化的研究进展[J]. 药学进展, 2016, 40 (10): 730-738.

[35]习斌斌, 徐敏, 李德坤, 周大铮, 杨悦武, 寇俊萍, 鞠爱春. HPLC-ELSD测定注射用益气复脉(冻干)中钠离子含量[J]. 药物分析杂志, 2016, 36 (08): 1503-1507.

[36]俞苏岚, 余秀, 寇俊萍. 天然产物防治急性肺损伤的作用机制研究进展[J]. 中国药科大学学报, 2016, 47 (04): 397-403.

[37]唐友梅, 曹国胜, 余秀, 张媛媛, 寇俊萍. 非肌肉肌球蛋白ⅡA的相互作用蛋白研究进展[J]. 现代生物医学进展, 2016, 16 (21): 4159-4164.

[38]刘雪, 杨会芳, 李德坤, 周大铮, 杨悦武, 寇俊萍, 鞠爱春. HPLC-ELSD法测定不同产地麦冬及山麦冬中的果糖[J]. 中成药, 2016, 38 (04): 850-853.

[39]郑显杰, 庞力智, 韩玉潇, 李芳, 寇俊萍, 余伯阳. 注射用益气复脉(冻干)改善小鼠心肌缺血再灌注损伤的作用[J]. 中成药, 2016, 38 (03): 473-480.

[40]孙兰, 周军, 宗绍波, 丁岗, 王振中, 萧伟, 寇俊萍. 桂枝茯苓胶囊及其成分组合物抗子宫收缩作用及其机制[J]. 世界科学技术-中医药现代化, 2016, 18 (02): 274-278.

[41]庄先飞, 柴程芝, 寇俊萍, 余伯阳. 气阴两虚证易诱发心血管事件的实验研究[J]. 中国中医基础医学杂志, 2016, 22 (01): 47-49.

[42]章晨峰, 曹亮, 衡晴晴, 寇俊萍, 李娜, 丁岗, 王振中, 萧伟. 胆木叶片抗大鼠急性咽炎作用研究[J]. 中国实验方剂学杂志, 2015, 21 (23): 97-100.

[43]杨璐, 华宇威, 寇俊萍, 余伯阳. 组织因子与代谢性综合征的研究进展[J]. 现代生物医学进展, 2015, 15 (31): 6175-6178.

[44]申凯, 寇俊萍, 余伯阳. 中药有效成分抑制氧化应激诱导的神经细胞凋亡机制研究进展[J]. 中国药科大学学报, 2015, 46 (05): 532-540.

[45]周华娜, 姜楠, 韩雨薇, 寇俊萍. 中药调节内质网应激的研究进展[J]. 中国药科大学学报, 2015, 46 (04): 385-392.

[46]陈红林, 刘晗, 叶心怡, 寇俊萍. 中药活性成分改善缺血缺氧所致脑微血管内皮屏障功能损伤的研究进展[J]. 药学进展, 2015, 39 (06): 415-424.

[47]郑显杰, 庞力智, 寇俊萍, 余伯阳. 中药抗心肌缺血再灌注损伤的信号通路研究进展[J]. 药学进展, 2015, 39 (06): 425-436.

[48]柴程芝, 庄先飞, 陈茜, 寇俊萍, 严永清, 余伯阳. 基于“肺主治节”理论探讨生脉散防治心血管疾病作用机制研究设想[J]. 中国中医基础医学杂志, 2015, 21 (04): 390-392.

[49]王俊俊, 张俐, 郭青, 寇俊萍, 余伯阳, 谷丹华. 一测多评法测定8个银翘解毒系列制剂中的7种酚酸类成分的含量[J]. 药学学报, 2015, 50 (04): 480-485.

[50]莫蔚兰, 庄先飞, 柴程芝, 寇俊萍, 余伯阳. 慢性间歇性缺氧模型与气阴两虚型心脏病的相关性研究[J]. 世界中西医结合杂志, 2014, 9 (12): 1292-1295.

[51]张媛媛, 宁华蓉, 戚进, 寇俊萍, 余伯阳. 短葶山麦冬皂苷DT-13研究进展[J]. 中国药科大学学报, 2014, 45 (05): 593-598.

[52]佳娜提·达吾列提, 姜楠, 寇俊萍, 余伯阳. 调节细胞自噬的中药有效成分研究进展[J]. 中草药, 2014, 45 (16): 2283-2292.

[53]梁文琳, 谢达温, 丁岗, 孙永成, 李艳静, 寇俊萍, 段金廒, 萧伟. 顶空毛细管气相色谱法测定银杏叶片中大孔树脂残留物[J]. 世界科学技术-中医药现代化, 2014, 16 (08): 1772-1776.

[54]陈茜, 柴程芝, 寇俊萍, 余伯阳. 缺氧诱导肺损伤的病理机制研究进展[J]. 现代生物医学进展, 2014, 14 (23): 4566-4569+4581.

[55]孙敏慧, 张媛媛, 许少华, 寇俊萍, 余伯阳. 皂苷类成分对血管内皮细胞功能的调节作用研究进展[J]. 药学进展, 2014, 38 (06): 409-418.

[56]赵晶, 申凯, 寇俊萍, 余伯阳. 天然活性成分作用靶点识别及确证方法的研究进展[J]. 现代生物医学进展, 2014, 14 (17): 3369-3372+3361.

[57]杨浩鹏, 岳蕾, 蒋雯雯, 刘倩, 寇俊萍, 余伯阳. 薯蓣皂苷元对肿瘤坏死因子诱导的单核细胞组织因子表达的抑制作用研究(英文)[J]. 中国天然药物, 2013, 11 (06): 608-615.

[58]袁春丽, 孙立, 袁胜涛, 寇俊萍, 余伯阳. 麦冬有效成分的药理活性及作用机制研究进展[J]. 中国新药杂志, 2013, 22 (21): 2496-2502.

[59]李少霞, 吕燕妮, 寇俊萍, 余伯阳. 皂苷类成分抗神经细胞凋亡机制的研究进展[J]. 药学进展, 2013, 37 (10): 509-515.

[60]寇俊萍, 柴程芝, 余伯阳. 中药药理研究进展[J]. 药学进展, 2013, 37 (09): 428-432.

[61]王宇卿, 朱丹妮, 寇俊萍, 余伯阳. HPLC-ABTS-DAD在线检测生脉散和益气复脉粉针的体外抗氧化能力[J]. 中国实验方剂学杂志, 2013, 19 (16): 51-54.

[62]吕燕妮, 翟科峰, 寇俊萍, 余伯阳. 正交试验法优化生脉散中有效成分组方亲和介质的制备工艺[J]. 中国实验方剂学杂志, 2013, 19 (14): 6-9.

[63]杨浩鹏, 李龙, 柴程芝, 寇俊萍, 余伯阳, 严永清. 生脉注射液对小鼠局灶性脑缺血再灌注损伤后组织因子表达及相关信号通路的影响[J]. 中国实验方剂学杂志, 2013, 19 (14): 194-199.

[64]贺玉伟, 柴程芝, 寇俊萍, 戚进, 余伯阳. 甲状腺素诱导小鼠模型表观指征变化与阴虚火旺证的相关性研究[J]. 实验动物科学, 2013, 30 (02): 1-6+10.

[65]周科成, 佳娜提, 吴黄辉, 王锋, 胡伟, 寇俊萍. 急、慢性束缚应激对小鼠情绪和学习记忆能力的不同影响[J]. 神经解剖学杂志, 2013, 29 (02): 145-148.

[66]贺玉伟, 柴程芝, 寇俊萍, 戚进, 余伯阳. 玄参醇提物对甲状腺素诱导小鼠表观指征变化的作用[J]. 中药药理与临床, 2013, 29 (01): 87-90.

[67]张洁琼, 柴程芝, 寇俊萍, 余伯阳. 慢性缺氧模型与病证相关性的研究进展[J]. 现代生物医学进展, 2012, 12 (33): 6572-6577+6557.

[68]张媛媛, 刘吉华, 寇俊萍, 余军, 余伯阳. 短葶山麦冬皂苷DT-13通过抑制MMP-2/9抑制肺癌A549细胞粘附和侵袭的作用(英文)[J]. 中国天然药物, 2012, 10 (06): 436-440.

[69]李赛谋, 戚进, 寇俊萍. 来源于植物的天然二苯甲酮类化合物的研究现状[J]. 药学进展, 2012, 36 (10): 452-458.

[70]乐心逸, 柴程芝, 寇俊萍, 余伯阳. 葛根汤对缩宫素复合寒冷刺激诱导的寒湿凝滞型原发性痛经小鼠模型的影响[J]. 中国实验方剂学杂志, 2012, 18 (18): 174-177.

[71]庄先飞, 俞苏岚, 樊梦霖, 寇俊萍. 中药复方防治急性肺损伤的作用机制研究进展[J]. 中国实验方剂学杂志, 2012, 18 (17): 326-331.

[72]孙莉琼, 丁晓萍, 马生堂, 戚进, 寇俊萍, 余伯阳. 基于谱效整合指纹的体外活性与体内活性的生物等效性研究[J]. 世界科学技术(中医药现代化), 2012, 14 (03): 1623-1630.

[73]柴程芝, 寇俊萍, 王文萍, 朱丹妮, 严永清, 余伯阳. 基于中医临床诊疗模式构建气阴两虚证动物模型的构想与初步探索[J]. 世界科学技术(中医药现代化), 2012, 14 (03): 1590-1594.

[74]柴程芝, 寇俊萍, 朱丹妮, 余伯阳. 葛根汤辨证治疗原发性痛经[J]. 世界中西医结合杂志, 2012, 7 (03): 244-246.

[75]马生堂, 寇俊萍, 余伯阳. 植物中皂苷类成分的毒性研究近况[J]. 药学进展, 2012, 36 (03): 110-115.

[76]宋佳希, 马丽, 寇俊萍, 余伯阳. 薯蓣皂苷元对白细胞的粘附与迁移及内皮细胞ICAM-1的表达和NF-κB活化的影响(英文)[J]. 中国天然药物, 2012, 10 (02): 142-149.

[77]王文萍, 柴程芝, 寇俊萍, 朱丹妮, 严永清, 余伯阳. 基于“方证相应”理论验证慢性间歇性缺氧模型气阴两虚证候属性的初步研究[J]. 中国中医基础医学杂志, 2012, 18 (01): 50-52.

[78]陈林霖, 戚进, 寇俊萍, 余伯阳, 朱丹妮. 当归芍药散配伍对主要成分体内吸收影响的研究[J]. 中国实验方剂学杂志, 2012, 18 (01): 121-124.

[79]王文萍, 柴程芝, 寇俊萍, 余伯阳. 2种慢性间歇性缺氧小鼠模型模拟气阴两虚证临床指征的比较研究[J]. 中国实验方剂学杂志, 2011, 17 (17): 171-176.

[80]高珍, 寇俊萍, 柴程芝, 余伯阳, 严永清. 逍遥丸对慢性束缚应激小鼠行为学和神经递质含量的影响[J]. 中国实验方剂学杂志, 2011, 17 (16): 174-176.

[81]陈玲, 寇俊萍, 余伯阳. 小檗碱抑制组织因子活性和静脉血栓形成的实验研究[J]. 中草药, 2011, 42 (07): 1389-1392.

[82]田友清, 寇俊萍, 李林洲, 余伯阳. 短葶山麦冬水提物及其主要有效部位和成的抗炎活性(英文)[J]. 中国天然药物, 2011, 9 (03): 222-226.

[83]胡银燕, 刘吉华, 寇俊萍, 余伯阳. 5种四氢原小檗碱类化合物的镇痛药效学研究[J]. 南京晓庄学院学报, 2011, 27 (03): 55-58.

[84]蒋文雯, 寇俊萍, 张红, 余伯阳. 川芎嗪对脂多糖诱导的单核细胞组织因子表达的抑制作用[J]. 中国药科大学学报, 2011, 42 (02): 145-148.

[85]曹旦华, 高珍, 寇俊萍, 朱丹妮. 2种当归芍药散提取物的镇痛活性与化学成分差异分析[J]. 中国实验方剂学杂志, 2010, 16 (16): 89-93.

[86]刘倩, 寇俊萍, 黄娅琳, 乐心逸, 余伯阳. 以人参皂苷Rg1为配基的亲和色谱介质的制备与初步应用[J]. 中国药科大学学报, 2010, 41 (05): 451-455.

[87]颜景峰, 李金平, 寇俊萍, 余伯阳. 鲁斯可皂苷元对小鼠脑缺血缺氧的保护作用[J]. 中药新药与临床药理, 2010, 21 (04): 331-334.

[88]寇俊萍*, 柴程芝, 高珍, 余伯阳, 朱丹妮, 严永清. 从1型组胺受体途径探索当归芍药散异病同治原理的研究构想[J]. 世界科学技术(中医药现代化), 2010, 12 (03): 325-330.

[89]孙祺, 邵方娴, 李晶晶, 王俊, 寇俊萍, 余伯阳. 调节组织因子功能的中药有效成分研究进展[J]. 中草药, 2010, 41 (03): 488-491.

[90]岳蕾, 陈玲, 寇俊萍, 余伯阳. 薯蓣皂苷元药理活性及其机制研究进展[J]. 中国临床药理学与治疗学, 2010, 15 (02): 233-237.

[91]马宏跃, 寇俊萍, 余伯阳. 六神丸抗炎镇痛活性的主药分析研究[J]. 江苏中医药, 2010, 42 (02): 74-75.

[92]柴程芝, 刘志刚, 寇俊萍, 朱丹妮, 余伯阳. 基于“体质-疾病谱-主症”模式的当归芍药散方证文献研究[J]. 辽宁中医杂志, 2009, 36 (12): 2078-2080.

[93]柴程芝, 刘志刚, 寇俊萍, 朱丹妮, 余伯阳. 当归芍药散医案药物剂量研究[J]. 中医杂志, 2009, 50 (11): 1042-1044.

[94]宋佳希, 寇俊萍, 余伯阳. 非肌肉肌球蛋白重链ⅡA(NMHCⅡA)生理病理功能研究进展[J]. 现代生物医学进展, 2009, 9 (20): 3964-3967+3979.

[95]柴程芝, 寇俊萍, 朱丹妮, 严永清, 余伯阳. 关于病证结合动物模型研究现状的思考[J]. 中国中药杂志, 2009, 34 (20): 2673-2675.

[96]高珍, 崔征, 寇俊萍. 组胺H1受体功能及调节机制研究进展[J]. 现代生物医学进展, 2009, 9 (19): 3768-3771.

[97]马宏跃, 寇俊萍, 余伯阳. 蟾酥抗链球菌感染的活性物质基础研究[J]. 中药药理与临床, 2009, 25 (04): 47-50.

[98]张启春, 寇俊萍, 朱丹妮, 严永清, 王秋娟. 尼莫地平含药脑脊液对体外PC12细胞损伤的保护作用[J]. 中国现代应用药学, 2009, 26 (05): 345-348.

[99]黄娅琳, 寇俊萍, 宋佳希, 余伯阳. RNA干扰技术抑制人内皮细胞非肌肉肌球蛋白重链ⅡA(MYH9)表达的研究[J]. 细胞与分子免疫学杂志, 2008, 24 (12): 1160-1163.

[100]王清正, 寇俊萍, 马宏跃, 沈花, 严永清, 余伯阳. 六神丸精简方抗炎镇痛活性的初步研究[J]. 中药新药与临床药理, 2008, (03): 180-183.

[101]孙晓, 寇俊萍, 李丁娟, 余伯阳. 当归芍药散对卵巢摘除小鼠行为学变化的影响[J]. 中国实验方剂学杂志, 2008, (05): 44-46.

[102]寇俊萍, 朱丹妮, 余伯阳, 严永清. 中药复方系统研究中药理研究的思路与实践[J]. 中药新药与临床药理, 2008, (01): 73-76+80.

[103]牟玲丽, 寇俊萍, 朱丹妮, 余伯阳. 银杏叶的化学成分及其抗氧化活性[J]. 中国天然药物, 2008, (01): 26-29.

[104]林以宁, 朱丹妮, 寇俊萍, 余伯阳. 麦冬类药材皂苷元含量与其抑制中性粒细胞呼吸爆发的相关性[J]. 中国药科大学学报, 2007, (06): 549-552.

[105]尤燕, 寇俊萍, 余伯阳, 严永清. 复方丹参片合生脉饮抗小鼠心肌缺氧缺血作用研究[J]. 中药药理与临床, 2007, (05): 4-7.

[106]寇俊萍, 吴彦, 王清正, 余伯阳, 严永清. 生黄连或酒制黄连对交泰丸镇静催眠作用的影响[J]. 中药药理与临床, 2007, (05): 15-17.

[107]巴拉, 袁艳红, 寇俊萍, 余伯阳. 小檗碱静脉注射及鼻腔给予在大鼠血浆与海马中的药代动力学研究(英文)[J]. 药物生物技术, 2007, (05): 348-355.

[108]张启春, 寇俊萍, 朱丹妮, 王秋娟, 严永清. 脑脊液药理实验条件规范化初探——当归芍药散精简方的神经保护作用[J]. 中国实验方剂学杂志, 2007, (08): 10-13.

[109]张建宏, 寇俊萍, 朱丹妮, 严永清, 余伯阳. 生脉散抗小鼠脑缺血缺氧有效组分的配伍研究[J]. 中药新药与临床药理, 2007, (04): 253-256.

[110]王洁, 寇俊萍. 退热贴的急性毒性、刺激性及过敏性试验观察[J]. 药学与临床研究, 2007, (02): 165-166.

[111]蒋文雯, 寇俊萍, 余伯阳. 抑制组织因子活性的天然化合物研究近况[J]. 药学进展, 2007, (03): 104-109.

[112]田友清, 丁平, 寇俊萍, 余伯阳. 薯蓣皂苷元对小鼠下腔静脉结扎血栓形成及相关因子的影响[J]. 现代中药研究与实践, 2007, (01): 32-34.

[113]范麒如, 寇俊萍, 张伟, 余伯阳. 天然雄黄与精制雄黄对小鼠肝脏损伤的初步研究[J]. 中国天然药物, 2007, (01): 63-67.

[114]严永清, 朱丹妮, 余伯阳, 寇俊萍, 林志宏. 中药复方系统研究的思路与实践[J]. 中国天然药物, 2006, (05): 322-326.

[115]邓润洁, 寇俊萍, 余伯阳. 中药有效成分抗血小板聚集作用机制研究进展[J]. 海峡药学, 2006, (04): 7-10.

[116]蓝妍敏, 寇俊萍, 余伯阳. 中药用于改善化疗所致消化道副作用的研究现状[J]. 药学进展, 2006, (07): 7304-7307.

[117]马丽, 寇俊萍, 黄跃, 余伯阳. 鲁斯可皂苷元对HL-60与EC V304细胞黏附的影响[J]. 中国药理学通报, 2006, (06): 706-709.

[118]张启春,王秋娟,寇俊萍,朱丹妮,严永清,余伯阳. 当归芍药散防治老年期痴呆的物质基础与作用机理研究VI——当归芍药散精简方含药脑脊液对PC12细胞的保护作用[J]. 中国实验方剂学杂志, 2005, (05): 55-58.

[119]寇俊萍,马仁强,闫瑾,胡玲燕,马勇,张炜. 贝贝清热贴解热、抗炎作用[J]. 中药新药与临床药理, 2004, (05): 330-332.

[120]田友清,余伯阳,寇俊萍. 麦冬药理研究进展[J]. 中国医学生物技术应用, 2004, (02): 1-5.

[121]寇俊萍,裴兴辰,余伯阳,朱丹妮,严永清. 生脉散总皂苷对实验性心肌缺氧保护作用的研究[J]. 中医药学刊, 2004, (05): 822-824.

[122]寇俊萍,马仁强,洪敏,余黎,张炜,马勇. 经痛安贴剂治疗痛经药理作用的实验研究[J]. 中国中医药科技, 2004, (02): 79-81.

[123]张伟,余伯阳,寇俊萍,王静蓉. 雄黄活性物质的毒效相关性初步研究[J]. 中国天然药物, 2004, (02): 62-64.

[124]寇俊萍,禹志领,龚树强,严永清. 小承气汤、厚朴大黄汤及厚朴三物汤药理作用[J]. 中成药, 2004, (01): 59-61.

[125]寇俊萍,唐新娟,庄书斐,童纯宁,严永清. 补益气血方剂对血液流变性的影响[J]. 中医药学报, 2003, (05): 28-30+68.

[126]寇俊萍,马仁强,朱丹妮,严永清. 黄花倒水莲对梅尼埃病症状模型和病理模型的影响[J]. 中国民族民间医药杂志, 2003, (04): 218-220+248.

[127]寇俊萍,朱海容,唐新娟,童纯宁,严永清. 红芪对血液流变性的影响[J]. 中药药理与临床, 2003, (04): 22-24.

[128]寇俊萍,华敏,严永清. 当归芍药散对小鼠免疫功能的影响[J]. 中国现代应用药学, 2003, (03): 171-173.

[129]寇俊萍,李景峰,闫瑾,朱丹妮. 黄花倒水莲总皂苷对凝血系统及血栓形成的影响[J]. 中国药科大学学报, 2003, (03): 63-65.

[130]寇俊萍,马仁强,朱丹妮,严永清. 黄花倒水莲水提液的活血、抗炎作用研究[J]. 中药材, 2003, (04): 268-271.

[131]寇俊萍,严永清,王霆,元海容. 当归芍药散及其含药血清对离体海马脑片拟缺血样损伤的作用[J]. 中医药学刊, 2003, (02): 198-199.

[132]寇俊萍,金卫峰,华敏,严永清. 当归芍药散对多种记忆损伤动物模型的影响[J]. 中成药, 2002, (03): 33-35.

[133]寇俊萍,华敏,朱丹妮,严永清. 当归芍药散对脑缺血再灌注所致记忆损伤模型小鼠的影响[J]. 中国现代应用药学, 2001, (05): 343-345.

[134]寇俊萍,庄书斐,唐新娟,童纯宁,严永清. 丝瓜藤醇提取物抗炎和抗过敏作用的研究[J]. 中国药科大学学报, 2001, (04): 55-58.

[135]寇俊萍,宣圆圆,严永清. 影响厚朴三物汤厚朴酚含量因素的初步研究[J]. 中成药, 2001, (06): 13-15.

[136]汤明辉,寇俊萍,朱丹妮,严永清. 正交设计-重复试验法优选当归芍药散的提取工艺[J]. 中国中药杂志, 2000, (11): 28-31.

[137]寇俊萍,严永清. 早老年性痴呆(AD)动物模型研究进展[J]. 江苏药学与临床研究, 1999, (03): 1-3.

[138]寇俊萍,刘颖,朱丹妮,华敏,严永清. 小承气汤等三方泻下作用差异物质基础研究[J]. 时珍国医国药, 1999, (06): 401-403.

[139]禹志领,严永清,吕建锋,寇俊萍. 六味地黄汤对雷公藤多甙损伤小鼠精子的影响[J]. 时珍国医国药, 1999, (02): 5-6.

[140]寇俊萍,禹志领,田景萱,马世平,严永清. 益智丸对小鼠记忆、脑内SOD、MDA及免疫功能的影响[J]. 中国中药杂志, 1997, (08): 46-49+66.

[141]寇俊萍,禹志领,刘中,马世平,严永清. 当归芍药散对小鼠学习记忆及脑内SOD、MDA的影响[J]. 中国实验方剂学杂志, 1997, (04): 25-28.

会议论文：

[1]Li, Fang; Fan, Xiaoxue; Zhang, Yu; Kou, Junping; Yu, Boyang.A strategy for optimization and cardioprotective validation by combination of three compounds based on Chinese medicinal formula Sheng-Mai-San for myocardial ischemia.Experimental Biology Meeting (EB), 2019-04-06 To 2019-04-09.

[2]Gong, Shuaishuai; Li, Fang; Kou, Jun-ping.NMMHC IIA Regulates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Modulating MAPKs and LATS1/2/YAP signaling pathways.Experimental Biology Meeting (EB), 2019-04-06 To 2019-04-09.

[3]王静蓉, 寇俊萍, 丘丽芳, 宗皖容, 严通萌 & 姜志宏. (2016). 人参RNA的抗心肌缺血活性研究. (eds.) 中国化学会第30届学术年会摘要集-第二十八分会：化学生物学 (pp.229).

[4]翟科峰; 唐友梅; 张媛媛; 寇俊萍.NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3β-NF-κB signaling pathways in the endothelium.江苏省药理学会"科技创新引领药理学科新发展"青年科技论坛, China, 2015-04-24 to 2015-04-26.

[5]翟科峰; 唐友梅; 张媛媛; 寇俊萍. 麦冬皂苷D39抑制组织因子表达和静脉血栓形成的作用机制研究.江苏省药理学会中药药理学术论坛暨药物毒理专业委员会成立大会, 中国, 2015-01-16至2015-01-16.

[6]俞苏岚 & 寇俊萍. (2015). 鲁斯可皂苷元改善脂多糖诱导急性肺损伤的作用研究. (eds.) 第十五届中国中西医结合学会微循环专业委员会暨第二届中国微循环学会痰瘀专业委员会学术会议资料汇编 (pp.68).

[7]谭伊莎; 李芳; 吕燕妮; 翟科峰; 柴程芝; 寇俊萍; 余伯阳.注射用益气复脉(冻干)防治心脑缺血的信号网络构建与验证研究.中国药理学会网络药理学专业委员会成立大会暨首届网络药理学学术会议, 2014-12-12.

[8]柴程芝, 寇俊萍, 朱丹妮, 严永清 & 余伯阳. (2013). 基于“肺主治节”理论探讨生脉散防治心血管疾病作用机制的研究设想. (eds.) 第九次全国中西医结合基础理论研究学术研讨会论文汇编 (pp.68-71).

[9]杨浩鹏, 郭中顺, 寇俊萍 & 余伯阳. (2012). 生脉注射液改善小鼠脑缺血再灌注损伤的作用机制研究. (eds.) 全国中药药理学会联合会学术交流大会论文摘要汇编 (pp.12).

[10]周科成, 尹俊滨, 寇俊萍, 王文 & 李云庆. (2012). 当归芍药散对福尔马林诱导小鼠疼痛反应和情绪障碍的改善作用. (eds.) 全国中药药理学会联合会学术交流大会论文摘要汇编 (pp.14).

[11]高梦雨, 陈玲, 余海翔, 孙祺, 寇俊萍 & 余伯阳. (2012). 薯蓣皂苷元改善脂多糖诱导的小鼠肺损伤的活性及初步机制研究. (eds.) 全国中药药理学会联合会学术交流大会论文摘要汇编 (pp.23).

[12]庄先飞, 俞晨洁, 樊梦霖, 俞苏岚, 张明 & 寇俊萍. (2012). 姜黄素衍生物4-HC对脂多糖诱导小鼠肺损伤的影响. (eds.) 全国中药药理学会联合会学术交流大会论文摘要汇编 (pp.23).

[13]张媛媛, 刘吉华, 寇俊萍 & 余伯阳. (2012). 短葶山麦冬皂苷DT-13抑制肺癌细胞A549粘附和侵袭的作用. (eds.) 全国中药药理学会联合会学术交流大会论文摘要汇编 (pp.24).

[14]贺玉伟, 柴程芝, 戚进, 寇俊萍 & 余伯阳. (2012). 甲状腺素诱导小鼠模型表观指征变化与阴虚火旺证的相关性研究. (eds.) 全国中药药理学会联合会学术交流大会论文摘要汇编 (pp.65).

[15]赵晶, 张冠军, 刘静, 寇俊萍 & 余伯阳. (2012). 肌球蛋白Ⅱ ATP酶活性微量方法的优化及其初步应用. (eds.) 全国中药药理学会联合会学术交流大会论文摘要汇编 (pp.65-66).

[16]柴程芝, 寇俊萍, 王文萍, 朱丹妮, 严永清 & 余伯阳. (2012). 基于中医临床诊疗模式构建气阴两虚证动物模型的构想与初步探索. (eds.) 第十届中国实验动物科学年会论文集 (pp.115-120).

[17]Liu Q; Kou J; Guan T; Wang Y; Yu B.Ginsenoside Rg1 Protect Oxidative Injured Neurons via Regulating on HSP90 and NF-kappa B

[18]严永清; 朱丹妮; 寇俊萍; 柴程芝.中药复方药效物质基础与作用机理研究思路与实践.中国实验方剂学编委会暨中药复方高端论坛大会报告, 中国, 2010-09-05至2010-09-07.

[19]高珍, 寇俊萍*, 余伯阳 & 严永清. (2010). 逍遥丸对慢性束缚应激小鼠行为学和神经递质含量的影响. (eds.) 2010年中国药学大会暨第十届中国药师周论文集 (pp.1335-1343).

[20]寇俊萍, 黄娅琳 & 余伯阳. (2008). 以系列亲和色谱技术为先导探索发现中药有效成分的直接作用靶标. (eds.) 药学发展前沿论坛及药理学博士论坛论文集 (pp.115-116).

[21]尤燕, 寇俊萍, 余伯阳 & 严永清. (2007). 复方丹参片合生脉饮抗小鼠心肌缺氧缺血作用研究. (eds.) 第十届全国中药药理学术会议论文集 (pp.6-9).

[22]寇俊萍, 吴彦, 王清正, 余伯阳 & 严永清. (2007). 生黄连或酒制黄连对交泰丸镇静催眠作用的影响. (eds.) 第十届全国中药药理学术会议论文集 (pp.17-19).

[23]严永清, 余伯阳, 朱丹妮, 寇俊萍, 林志宏 & 王鹏. (2004). 防治血管性痴呆新药的研究. (eds.) 第四次全国中西医结合养生学与康复医学学术研讨会论文集 (pp.10-11).

[24]朱丹妮, 王秋娟, 高山林, 寇俊萍 & 严永清. (2003). 黄花倒水莲总苷降脂新药的研制与开发. (eds.) 海峡两岸中西医结合学术研讨会论文集 (pp.116).

[25]严永清 & 寇俊萍. (2000). 当归芍药散防治老年性痴呆的药效学研究及作用机理初步探讨. (eds.) 西部大开发科教先行与可持续发展——中国科协2000年学术年会文集 (pp.1221).

寇俊萍 中国药科大学教授

寇俊萍中国药科大学教授